<!DOCTYPE html>
 <!--[if lt IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8 lt-ie7"> <![endif]--> <!--[if IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8"> <![endif]--> <!--[if IE 8]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9"> <![endif]--> <!--[if gt IE 8]><!--> <html class="aui ltr" dir="ltr" lang="en-US" prefix="og: http://ogp.me/ns#"> <!--<![endif]--> <head> <title>Intravenous immunoglobulin for presumed viral myocarditis in children and adults - Robinson, J - 2020 | Cochrane Library</title> <meta content="Intravenous immunoglobulin for presumed viral myocarditis in children and adults - Robinson, J - 2020 | Cochrane Library" property="og:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD004370.pub4/full" property="og:url"/> <meta content="article" property="og:type"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" property="og:image"/> <meta content="summary_large_image" name="twitter:card"/> <meta content="Intravenous immunoglobulin for presumed viral myocarditis in children and adults - Robinson, J - 2020 | Cochrane Library" name="twitter:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD004370.pub4/full" name="twitter:url"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" name="twitter:image"/> <meta content="initial-scale=1.0, width=device-width" name="viewport"/> <meta content="10.1002/14651858.CD004370.pub4" name="dc.identifier" scheme="DOI"/> <meta content="Intravenous immunoglobulin for presumed viral myocarditis in children and adults" name="citation_title"/> <meta content="Joan Robinson" name="citation_author"/> <meta content="University of Alberta" name="citation_author_institution"/> <meta content="jr3@ualberta.ca" name="citation_author_email"/> <meta content="Lisa Hartling" name="citation_author"/> <meta content="University of Alberta" name="citation_author_institution"/> <meta content="Ben Vandermeer" name="citation_author"/> <meta content="University of Alberta" name="citation_author_institution"/> <meta content="Meghan Sebastianski" name="citation_author"/> <meta content="University of Alberta" name="citation_author_institution"/> <meta content="Terry P Klassen" name="citation_author"/> <meta content="Manitoba Institute of Child Health" name="citation_author_institution"/> <meta content="Cochrane Database of Systematic Reviews" name="citation_journal_title"/> <meta content="John Wiley &amp; Sons, Ltd" name="citation_publisher"/> <meta content="8" name="citation_issue"/> <meta content="10.1002/14651858.CD004370.pub4" name="citation_doi"/> <meta content="2020" name="citation_date"/> <meta content="2020/08/19" name="citation_online_date"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD004370.pub4/abstract" name="citation_abstract_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD004370.pub4/full" name="citation_fulltext_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD004370.pub4/pdf/full" name="citation_pdf_url"/> <meta content="1465-1858" name="citation_issn"/> <meta content="en" name="citation_language"/> <meta content="Acute Disease; Bias; Immunoglobulins, Intravenous [*therapeutic use]; Myocarditis [mortality, *therapy, virology]; Progression-Free Survival; Randomized Controlled Trials as Topic; Stroke Volume [drug effects]; Virus Diseases [mortality, *therapy]" name="citation_keywords"/> <link href="https://fonts.googleapis.com/css?family=Source+Sans+Pro:400,700,600,900" rel="stylesheet"/> <script src="https://cmp.osano.com/AzZdRbSORDOOzF9W/d594efc1-9663-477d-9528-6576640e64fd/osano.js"></script> <style> .osano-cm-widget{display: none;} </style> <script src="https://static.addtoany.com/menu/page.js"></script> <script async="" charset="utf-8" src="https://platform.twitter.com/widgets.js"></script> <script async="async" src="//script.crazyegg.com/pages/scripts/0056/6375.js" type="text/javascript"></script> <script type="text/javascript">window.dataLayer={};var xtend=function(){var a={};var b=false;var c=0;var d=arguments.length;if(Object.prototype.toString.call(arguments[0])==="[object Boolean]"){b=arguments[0];c++}var f=function(g){for(var h in g){if(Object.prototype.hasOwnProperty.call(g,h)){if(b&&Object.prototype.toString.call(g[h])==="[object Object]"){a[h]=xtend(true,a[h],g[h])}else{a[h]=g[h]}}}};for(;c<d;c++){var e=arguments[c];f(e)}return a};</script> <!-- Global site tag (gtag.js) - Google Analytics --> <script src="https://www.googletagmanager.com/gtag/js?id=UA-189672-63&amp;l=gDataLayer"></script> <script>window.gDataLayer=window.gDataLayer||[];function gtag(){gDataLayer.push(arguments)}gtag("js",new Date());gtag("config","UA-189672-63");</script> <script type="text/javascript">var o={auth:{customerIds:[],individualId:null,brandedCustomer:null,roles:["Guest"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <script type="text/javascript">var o={page:{siteSection:"Content",languageCode:"en",cms:{pageTitle:"Content"}}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <meta content="text/html; charset=utf-8" http-equiv="content-type"/> <link href="https://www.cochranelibrary.com/cochrane-theme/images/favicon.ico" rel="Shortcut Icon"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD004370.pub4&amp;doi=10.1002/14651858.CD004370.pub4&amp;type=cdsr&amp;contentLanguage=" rel="canonical"/> <link href="https://www.cochranelibrary.com/zh/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD004370.pub4&amp;doi=10.1002/14651858.CD004370.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANS" rel="alternate"/> <link href="https://www.cochranelibrary.com/zh_HANT/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD004370.pub4&amp;doi=10.1002/14651858.CD004370.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANT" rel="alternate"/> <link href="https://www.cochranelibrary.com/hr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD004370.pub4&amp;doi=10.1002/14651858.CD004370.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="hr-HR" rel="alternate"/> <link href="https://www.cochranelibrary.com/nl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD004370.pub4&amp;doi=10.1002/14651858.CD004370.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="nl-NL" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD004370.pub4&amp;doi=10.1002/14651858.CD004370.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="x-default" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD004370.pub4&amp;doi=10.1002/14651858.CD004370.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="en-US" rel="alternate"/> <link href="https://www.cochranelibrary.com/fr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD004370.pub4&amp;doi=10.1002/14651858.CD004370.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="fr-FR" rel="alternate"/> <link href="https://www.cochranelibrary.com/de/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD004370.pub4&amp;doi=10.1002/14651858.CD004370.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="de-DE" rel="alternate"/> <link href="https://www.cochranelibrary.com/hi/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD004370.pub4&amp;doi=10.1002/14651858.CD004370.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="hi-HI" rel="alternate"/> <link href="https://www.cochranelibrary.com/hu/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD004370.pub4&amp;doi=10.1002/14651858.CD004370.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="hu-HU" rel="alternate"/> <link href="https://www.cochranelibrary.com/in/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD004370.pub4&amp;doi=10.1002/14651858.CD004370.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="in-ID" rel="alternate"/> <link href="https://www.cochranelibrary.com/ja/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD004370.pub4&amp;doi=10.1002/14651858.CD004370.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="ja-JP" rel="alternate"/> <link href="https://www.cochranelibrary.com/ko/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD004370.pub4&amp;doi=10.1002/14651858.CD004370.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="ko-KR" rel="alternate"/> <link href="https://www.cochranelibrary.com/ms/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD004370.pub4&amp;doi=10.1002/14651858.CD004370.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="ms-MY" rel="alternate"/> <link href="https://www.cochranelibrary.com/fa/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD004370.pub4&amp;doi=10.1002/14651858.CD004370.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="fa-IR" rel="alternate"/> <link href="https://www.cochranelibrary.com/pl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD004370.pub4&amp;doi=10.1002/14651858.CD004370.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="pl-PL" rel="alternate"/> <link href="https://www.cochranelibrary.com/pt/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD004370.pub4&amp;doi=10.1002/14651858.CD004370.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="pt-PT" rel="alternate"/> <link href="https://www.cochranelibrary.com/ro/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD004370.pub4&amp;doi=10.1002/14651858.CD004370.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="ro-RO" rel="alternate"/> <link href="https://www.cochranelibrary.com/ru/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD004370.pub4&amp;doi=10.1002/14651858.CD004370.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="ru-RU" rel="alternate"/> <link href="https://www.cochranelibrary.com/es/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD004370.pub4&amp;doi=10.1002/14651858.CD004370.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="es-ES" rel="alternate"/> <link href="https://www.cochranelibrary.com/ta/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD004370.pub4&amp;doi=10.1002/14651858.CD004370.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="ta-IN" rel="alternate"/> <link href="https://www.cochranelibrary.com/th/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD004370.pub4&amp;doi=10.1002/14651858.CD004370.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="th-TH" rel="alternate"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734739000" rel="stylesheet" type="text/css"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/aui.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734739000" rel="stylesheet" type="text/css"/> <link href="/html/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773519000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/scolaris-content-display/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/notifications-portlet/notifications/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/html/portlet/login/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773548000" rel="stylesheet" type="text/css"/> <script type="text/javascript">var Liferay={Browser:{acceptsGzip:function(){return false},getMajorVersion:function(){return 80},getRevision:function(){return"537.36"},getVersion:function(){return"80.0"},isAir:function(){return false},isChrome:function(){return true},isFirefox:function(){return false},isGecko:function(){return true},isIe:function(){return false},isIphone:function(){return false},isLinux:function(){return true},isMac:function(){return false},isMobile:function(){return false},isMozilla:function(){return false},isOpera:function(){return false},isRtf:function(){return true},isSafari:function(){return true},isSun:function(){return false},isWap:function(){return false},isWapXhtml:function(){return false},isWebKit:function(){return true},isWindows:function(){return false},isWml:function(){return false}},Data:{NAV_SELECTOR:"#navigation",isCustomizationView:function(){return false},notices:[null]},ThemeDisplay:{getLayoutId:function(){return"7"},getLayoutURL:function(){return"https://www.cochranelibrary.com/en/content"},getParentLayoutId:function(){return"0"},isPrivateLayout:function(){return"false"},isVirtualLayout:function(){return false},getBCP47LanguageId:function(){return"en-US"},getCDNBaseURL:function(){return"https://www.cochranelibrary.com"},getCDNDynamicResourcesHost:function(){return""},getCDNHost:function(){return""},getCompanyId:function(){return"20155"},getCompanyGroupId:function(){return"20195"},getDefaultLanguageId:function(){return"en_US"},getDoAsUserIdEncoded:function(){return""},getLanguageId:function(){return"en_US"},getParentGroupId:function(){return"20182"},getPathContext:function(){return""},getPathImage:function(){return"/image"},getPathJavaScript:function(){return"/html/js"},getPathMain:function(){return"/en/c"},getPathThemeImages:function(){return"https://www.cochranelibrary.com/cochrane-theme/images"},getPathThemeRoot:function(){return"/cochrane-theme"},getPlid:function(){return"20757"},getPortalURL:function(){return"https://www.cochranelibrary.com"},getPortletSetupShowBordersDefault:function(){return true},getScopeGroupId:function(){return"20182"},getScopeGroupIdOrLiveGroupId:function(){return"20182"},getSessionId:function(){return""},getSiteGroupId:function(){return"20182"},getURLControlPanel:function(){return"/group/control_panel?refererPlid=20757"},getURLHome:function(){return"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane"},getUserId:function(){return"20159"},getUserName:function(){return""},isAddSessionIdToURL:function(){return false},isFreeformLayout:function(){return false},isImpersonated:function(){return false},isSignedIn:function(){return false},isStateExclusive:function(){return false},isStateMaximized:function(){return false},isStatePopUp:function(){return false}},PropsValues:{NTLM_AUTH_ENABLED:false}};var themeDisplay=Liferay.ThemeDisplay;Liferay.AUI={getAvailableLangPath:function(){return"available_languages.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1513680837000"},getCombine:function(){return true},getComboPath:function(){return"/combo/?browserId=other&minifierType=&languageId=en_US&b=6210&t=1513680837000&"},getFilter:function(){return"min"},getJavaScriptRootPath:function(){return"/html/js"},getLangPath:function(){return"aui_lang.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1513680837000"},getStaticResourceURLParams:function(){return"?browserId=other&minifierType=&languageId=en_US&b=6210&t=1513680837000"}};Liferay.authToken="WbpyPs9C";Liferay.currentURL="\x2fweb\x2fcochrane\x2fcontent\x3ftemplateType\x3dfull\x26urlTitle\x3d\x2fcdsr\x2fdoi\x2f10\x2e1002\x2f14651858\x2eCD004370\x2epub4\x26doi\x3d10\x2e1002\x2f14651858\x2eCD004370\x2epub4\x26type\x3dcdsr\x26contentLanguage\x3d";Liferay.currentURLEncoded="\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD004370\x2epub4\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD004370\x2epub4\x2526type\x253Dcdsr\x2526contentLanguage\x253D";</script> <script src="/html/js/barebone.jsp?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;colorSchemeId=01&amp;minifierType=js&amp;minifierBundleId=javascript.barebone.files&amp;languageId=en_US&amp;b=6210&amp;t=1513680837000" type="text/javascript"></script> <script type="text/javascript"></script> <script type="text/javascript">var o={database:"CDSR",page:{pageType:"Article Full Text HTML"},article:{availableLanguage:["en","es","zh_HANS","zh_HANT","ru","ko","ms","hr","fa"],languageCode:"en",accessStatus:"delayed-free",doi:"10.1002/14651858.CD004370.pub4",title:"Intravenous immunoglobulin for presumed viral myocarditis in children and adults",firstPublishedDate:"Aug 19, 2020 12:00:00 AM",isCurrentVersion:true,editorialGroup:"Cochrane Heart Group",availableParts:["PDF Full","PDF Standard","PDF Abstract","HTML","Comments","Information","References","Stats","Related Content"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/custom.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734739000" rel="stylesheet" type="text/css"/> <style type="text/css"></style> <script async="" src="https://assets.adobedtm.com/59640f9fa510/7cad07cf7779/launch-a215d9c51521.min.js"></script> <!--[if lt IE 9]> <script src="/cochrane-theme/vendor/respond/dest/respond.min.js?t=1738734739000" type="text/javascript"></script> <![endif]--> </head> <body class="yui3-skin-sam controls-visible guest-site signed-out public-page site"> <div class="site-container"> <a href="#main-content" id="skip-to-content">Skip to Content</a> <div class="cookie-message cookie-message--hidden system-message-container" id="js-cookie-message"> <div class="container"> <a aria-label="Close cookies message" class="fa fa-times js-cookie-close pull-right" href="#"></a> <div class="system-message-wrapper container"> <i aria-hidden="true" class="fa fa-exclamation-triangle"></i> <div class="system-message-title">Cookies</div> <div class="system-message-description"> <p> Our site uses cookies to improve your experience. You can find out more about our use of cookies in About Cookies, including instructions on how to turn off cookies if you wish to do so. By continuing to browse this site you agree to us using cookies as described in <a href="http://olabout.wiley.com/WileyCDA/Section/id-813473.html">About Cookies</a>. </p> <a class="btn secondary js-cookie-close js-cookie-accept" href="#">I accept</a> </div> </div> </div> </div> <script>document.body.className=document.body.className+" js_enabled";</script><header> <div class="container"> <div class="branding"> <h1 class="brand-container"> <a href="https://www.cochranelibrary.com/en/"> <span class="brand-name">The Cochrane Library</span> <img alt="Cochrane Library logo" class="brand-logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_logo.png" title="Cochrane Library"/> </a> </h1> <span class="additional-branding"> <p class="brand-message"> <em>Trusted evidence.</em> <em>Informed decisions.</em> <em>Better health.</em> </p> </span> </div> <div class="desktop-search basic-search-container"> <div class="desktop-search-form"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="owel__null__null" src="/scolaris-search/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=WbpyPs9C&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"/> <input name="facetDisplayName" type="hidden" value=""/> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD004370.pub4&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD004370.pub4';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<div class="search-tools-nav">
<a class="btn secondary" href="/en/browse-by-topic">Browse</a>
<a class="btn primary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
</div>
<a class="toggle-menu-switch" href="#"><i aria-hidden="true" class="fa fa-bars"></i> <div class="toggle-menu-text">Open menu</div></a>
</div>
<div class="auxiliary-container">
<div class="container">
<div class="header-auxiliary-menu">
<div class="auxiliary-menu-item language-selector">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="bvrs__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> Review language : English </a> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> Website language : English </a> </div> <div class="language-selector-modal-content" data-modal-title="Language selection" data-size="large" style="display: none;"> <div class="form-content language-selector-modal"> <div class="row-fluid"> <div> <table class="mytable" style="border: 1px solid #f0f0f0" width="90%"> <tbody> <tr class="row-box"> <td><i class="fa fa-file-text icon-size"></i></td> <td><h3>Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> </td> <td> <div> <select id="contentLanguageSelector" onchange="updateLang(this.value)"> <option class="content-language-option" data-languagecode="de" value="de"> Deutsch </option> <option class="content-language-option" data-languagecode="en" selected="" value="en"> English </option> <option class="content-language-option" data-languagecode="es" value="es"> Español </option> <option class="content-language-option" data-languagecode="fa" value="fa"> فارسی </option> <option class="content-language-option" data-languagecode="fr" value="fr"> Français </option> <option class="content-language-option" data-languagecode="hi" value="hi"> हिन्दी </option> <option class="content-language-option" data-languagecode="hr" value="hr"> Hrvatski </option> <option class="content-language-option" data-languagecode="id" value="id"> Bahasa Indonesia </option> <option class="content-language-option" data-languagecode="ja" value="ja"> 日本語 </option> <option class="content-language-option" data-languagecode="ko" value="ko"> 한국어 </option> <option class="content-language-option" data-languagecode="hu" value="hu"> Magyar </option> <option class="content-language-option" data-languagecode="ms" value="ms"> Bahasa Malaysia </option> <option class="content-language-option" data-languagecode="nl" value="nl"> Nederlands </option> <option class="content-language-option" data-languagecode="pl" value="pl"> Polski </option> <option class="content-language-option" data-languagecode="pt" value="pt"> Português </option> <option class="content-language-option" data-languagecode="ru" value="ru"> Русский </option> <option class="content-language-option" data-languagecode="ro" value="ro"> Română </option> <option class="content-language-option" data-languagecode="ta" value="ta"> தமிழ் </option> <option class="content-language-option" data-languagecode="th" value="th"> ภาษาไทย </option> <option class="content-language-option" data-languagecode="zh_HANT" value="zh_HANT"> 繁體中文 </option> <option class="content-language-option" data-languagecode="zh_HANS" value="zh_HANS"> 简体中文 </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> <tr class="row-box"> <td><i class="fa fa-globe icon-size"></i></td> <td> <div class="language-info"> <h3>Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> </div> </td> <td> <div class="language-dropdown"> <select id="portalLanguageSelector"> <option class="portal-language-selector" data-portallanguage="en" selected="" value="/en/cdsr/doi/10.1002/14651858.CD004370.pub4/full/en"> English </option> <option class="portal-language-selector" data-portallanguage="es" value="/es/cdsr/doi/10.1002/14651858.CD004370.pub4/full/es"> Español </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> </tbody> </table> </div> </div> <div style="text-align: right;"> <button class="btn primary btn-cancel" style="margin-left: 10px;" type="button">Cancel</button> <a class="btn secondary ok-btn" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<a class="auxiliary-menu-item signin last" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD004370.pub4%2Ffull" rel="nofollow">
<i class="icon fa fa-user"></i> Sign In
    </a>
<span class="auxiliary-container-extended"></span>
</div>
</div>
</div>
</header>
<div class="main-nav-wrapper">
<span class="main-nav-left-extended"></span>
<nav class="main container">
<ul>
<li class="nav-root-item parent">
<a href="#">Cochrane reviews<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_14" role="presentation">
<a aria-labelledby="layout_14" href="https://www.cochranelibrary.com/en/cdsr/reviews" role="menuitem">
            Search reviews (CDSR)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_15" role="presentation">
<a aria-labelledby="layout_15" href="https://www.cochranelibrary.com/en/cdsr/reviews/topics" role="menuitem">
            Browse reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_18" role="presentation">
<a aria-labelledby="layout_18" href="https://www.cochranelibrary.com/en/cdsr/table-of-contents" role="menuitem">
            Issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_17" role="presentation">
<a aria-labelledby="layout_17" href="https://www.cochranelibrary.com/en/cdsr/editorials" role="menuitem">
            Editorials
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_19" role="presentation">
<a aria-labelledby="layout_19" href="https://www.cochranelibrary.com/en/special-collections" role="menuitem">
            Special Collections
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_20" role="presentation">
<a aria-labelledby="layout_20" href="https://www.cochranelibrary.com/en/cdsr/supplements" role="menuitem">
            Supplements
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_121" role="presentation">
<a aria-labelledby="layout_121" href="https://www.cochranelibrary.com/en/about/about-cochrane-reviews" role="menuitem">
            About Cochrane reviews
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Searching for trials<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_254" role="presentation">
<a aria-labelledby="layout_254" href="https://www.cochranelibrary.com/en/search/releases" role="menuitem">
            What's new (search and CENTRAL)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_266" role="presentation">
<a aria-labelledby="layout_266" href="https://www.cochranelibrary.com/en/search-help" role="menuitem">
            Search help
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_252" role="presentation">
<a aria-labelledby="layout_252" href="https://www.cochranelibrary.com/en/search-help-quick-guides" role="menuitem">
            Search help quick guides
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_251" role="presentation">
<a aria-labelledby="layout_251" href="https://www.cochranelibrary.com/en/search-faqs" role="menuitem">
            Search FAQs
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_114" role="presentation">
<a aria-labelledby="layout_114" href="https://www.cochranelibrary.com/en/central/about-central" role="menuitem">
            About CENTRAL
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_115" role="presentation">
<a aria-labelledby="layout_115" href="https://www.cochranelibrary.com/en/central/central-creation" role="menuitem">
            How CENTRAL is created
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_241" role="presentation">
<a aria-labelledby="layout_241" href="https://www.cochranelibrary.com/en/retracted-trials" role="menuitem">
            Retracted publications in CENTRAL
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Clinical Answers<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_29" role="presentation">
<a aria-labelledby="layout_29" href="https://www.cochranelibrary.com/en/cca" role="menuitem">
            Browse Clinical Answers
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_91" role="presentation">
<a aria-labelledby="layout_91" href="https://www.cochranelibrary.com/en/cca/about" role="menuitem">
            About Clinical Answers
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">About<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_116" role="presentation">
<a aria-labelledby="layout_116" href="https://www.cochranelibrary.com/en/about/about-cochrane-library" role="menuitem">
            About the Cochrane Library
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_13" role="presentation">
<a aria-labelledby="layout_13" href="https://www.cochranelibrary.com/en/cdsr/about-cdsr" role="menuitem">
            Cochrane Database of Systematic reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_198" role="presentation">
<a aria-labelledby="layout_198" href="https://www.cochranelibrary.com/en/cdsr/editorial-policies" role="menuitem">
            Editorial policies
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_92" role="presentation">
<a aria-labelledby="layout_92" href="https://www.cochranelibrary.com/en/about/author-information" role="menuitem">
            Information for authors
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_212" role="presentation">
<a aria-labelledby="layout_212" href="https://www.cochranelibrary.com/en/about-pico" role="menuitem">
            About PICO
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_207" role="presentation">
<a aria-labelledby="layout_207" href="https://www.cochranelibrary.com/en/about/about-translations" role="menuitem">
            About translations
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_188" role="presentation">
<a aria-labelledby="layout_188" href="https://www.cochranelibrary.com/en/about/releases" role="menuitem">
            What's new
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_216" role="presentation">
<a aria-labelledby="layout_216" href="https://www.cochranelibrary.com/en/data" role="menuitem">
            Data reuse
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_235" role="presentation">
<a aria-labelledby="layout_235" href="https://www.cochranelibrary.com/en/about/about-cochrane-library/editorial-board" role="menuitem">
            Cochrane Library Editorial Board
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Help<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_259" role="presentation">
<a aria-labelledby="layout_259" href="https://m.info.wiley.com/webApp/cochranenewsletter?id=0" role="menuitem">
            Newsletter
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_177" role="presentation">
<a aria-labelledby="layout_177" href="https://www.wiley.com/en-us/customer-success/cochrane-library-training-hub" role="menuitem">
            Cochrane Library Training
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_44" role="presentation">
<a aria-labelledby="layout_44" href="https://www.cochranelibrary.com/en/help/access" role="menuitem">
            Access
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_150" role="presentation">
<a aria-labelledby="layout_150" href="https://www.cochranelibrary.com/en/help/permissions" role="menuitem">
            Permissions and reprints
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_93" role="presentation">
<a aria-labelledby="layout_93" href="https://www.cochranelibrary.com/en/help/media" role="menuitem">
            Media information
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_97" role="presentation">
<a aria-labelledby="layout_97" href="https://www.cochranelibrary.com/en/help/contact-us" role="menuitem">
            Contact us
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_125" role="presentation">
<a aria-labelledby="layout_125" href="https://www.cochranelibrary.com/en/about/terms-and-conditions" role="menuitem">
            Terms and conditions
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_176" role="presentation">
<a aria-labelledby="layout_176" href="https://cochranesupport.wiley.com/s/article/cochrane-library-known-issues" role="menuitem">
            Known issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_270" role="presentation">
<a aria-labelledby="layout_270" href="https://www.cochranelibrary.com/search-help" role="menuitem">
            Search help
        </a>
</li>
</ul>
</li>
<li class="about-link"><a href="https://www.cochrane.org/about-us" target="_blank"><span>About Cochrane</span><i class="fa fa-caret-right"></i></a></li>
</ul>
</nav>
</div>
<div class="portlet-boundary portlet-boundary_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_">
<span id="p_scolariscontentlanguagebanner_WAR_scolarislanguageportlet"></span>
<section class="portlet" id="portlet_scolariscontentlanguagebanner_WAR_scolarislanguageportlet">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Language\x20Banner\x20Portlet')">
<img alt="" id="etlj__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Language Banner Portlet</span> </span> <span class="portlet-title-text">Scolaris Content Language Banner Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentlanguagebanner_WAR_scolarislanguageportlet" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="" id="content">
<div class="columns-1" id="main-content" role="main">
<div class="portlet-layout row-fluid">
<div class="portlet-column portlet-column-only span12" id="column-1">
<div class="portlet-dropzone portlet-column-content portlet-column-content-only" id="layout-column_column-1">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="rjus__column1__0" src="/scolaris-content-display/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="publication cdsr container"> <div class="article-navigation-container" id="cdsr-nav"> <nav class="article-navigation"> <ul class="tools-row"> <li> <li class="tools pdf pulldown-menu readcube-menu closed en_US"> <a class="pulldown-menu-trigger" href="#0"> <span class="pdf-icon"> <i class="icon fa fa-file-pdf-o"></i> <span>Download PDF</span> </span> <i aria-hidden="true" class="fa fa-caret-down"></i> </a> <ul class="pulldown-menu-items"> <li class=""> <a class="download media pdf-link-full pdf-link" href="/cdsr/doi/10.1002/14651858.CD004370.pub4/pdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> <a class="download media pdf-link-full readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD004370.pub4/epdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> </li> <li class=""> <a class="download media pdf-link-abstract pdf-link" href="/cdsr/doi/10.1002/14651858.CD004370.pub4/pdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> <a class="download media pdf-link-abstract readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD004370.pub4/epdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> </li> </ul> </li> <li class="tools cite cite-article-link" data-article-id="CD004370.PUB4" data-modal-title="Cite this review"> <span><i aria-hidden="true" class="icon fa fa-share"></i></span> <span>Cite this review</span> </li> </li> </ul> <ul class="tools-row tools-secondary"> <li> <li class="tools print print-cdsr-link" data-content-language="en" data-indicator-tooltip="scolaris.print.modal.language.tooltip.en" data-print-options="[{&quot;param&quot;: &quot;abstract&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Abstract&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;چکیده&quot;},{&quot;language&quot;:&quot;ko&quot;,&quot;title&quot;:&quot;초록&quot;},{&quot;language&quot;:&quot;zh_HANS&quot;,&quot;title&quot;:&quot;摘要&quot;}]},{&quot;param&quot;: &quot;pls&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Plain language summary&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen en términos sencillos&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;خلاصه به زبان ساده&quot;},{&quot;language&quot;:&quot;hr&quot;,&quot;title&quot;:&quot;Laički sažetak&quot;},{&quot;language&quot;:&quot;ko&quot;,&quot;title&quot;:&quot;쉬운 말 요약&quot;},{&quot;language&quot;:&quot;ms&quot;,&quot;title&quot;:&quot;Ringkasan bahasa mudah&quot;},{&quot;language&quot;:&quot;ru&quot;,&quot;title&quot;:&quot;Резюме на простом языке&quot;},{&quot;language&quot;:&quot;zh_HANS&quot;,&quot;title&quot;:&quot;简语概要&quot;},{&quot;language&quot;:&quot;zh_HANT&quot;,&quot;title&quot;:&quot;淺顯易懂的口語結論&quot;}]},{&quot;param&quot;: &quot;conclusions&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors' conclusions&quot;}]},{&quot;param&quot;: &quot;summaryOfFindings&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Summary of findings&quot;}]},{&quot;param&quot;: &quot;background&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Background&quot;}]},{&quot;param&quot;: &quot;objectives&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Objectives&quot;}]},{&quot;param&quot;: &quot;methods&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Methods&quot;}]},{&quot;param&quot;: &quot;results&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Results&quot;}]},{&quot;param&quot;: &quot;discussion&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Discussion&quot;}]},{&quot;param&quot;: &quot;references&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;References&quot;}]},{&quot;param&quot;: &quot;appendices&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Appendices&quot;},{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Search strategies&quot;}]},{&quot;param&quot;: &quot;characteristics&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Characteristics of studies&quot;}]},{&quot;param&quot;: &quot;data&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Analyses&quot;}]},{&quot;param&quot;: &quot;information&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Information&quot;}]},{&quot;param&quot;: &quot;authors&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors&quot;}]},{&quot;param&quot;: &quot;history&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;},{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;}]}]" data-print-urlbase="/cdsr/doi/10.1002/14651858.CD004370.pub4/print"> <span><i class="icon fa fa-print"></i></span> <span>Print</span> </li> <li class="js-old-version-modal-trigger tools comments comment-on-review" data-article-id="CD004370.PUB4" data-english-only-message="Please note, that commenting is available in English only. Apologies for any inconvenience." data-href="/cdsr/doi/10.1002/14651858.CD004370.pub4/read-comments" data-new-version="" id="comment-on-review"> <span class="comment-icon"><i class="icon fa fa-comment"></i></span> <span class="comments-count">0</span> <span>Comment</span> </li> <li class="tools share-cdsr-link" data-share-url="/cdsr/doi/10.1002/14651858.CD004370.pub4/full"> <span><i class="icon fa fa-share-alt"></i></span> <span>Share</span> </li> <li class="tools follow"> <span class="article-not-followed cochrane-link signin follow-wrapper"> <span> <i class="icon fa fa-plus"></i> </span> <span> Follow </span> </span> </li> </li> </ul> <div class="metrics-wrapper"> <div class="metrics-count"> <span>Full text views: </span> <span>4139 <i class="icon fa fa-info-circle custom-tooltip" style="padding-left: 2px;color: #962d91;" title="Usage represents full text views on Cochrane Library since January 2022 or 2023. For articles published after this date, the usage represents views since the article was first published on Cochrane Library."> </i> </span> </div> </div> <div class="metrics-wrapper nav-link-section"> <div class="altmetric-embed" data-badge-type="1" data-condensed="true" data-doi="10.1002/14651858.CD004370.pub4" data-link-target="_blank"></div> <div class="inline-status-wrapper guidelines-count" data-count-plural="Cited in $1 guidelines" data-count-single="Cited in 1 guideline"> <a href="related-content#guidelines_data" title="Guidelines"></a> </div> </div> <ul class="nav-section-header"> <li> <h3>Contents</h3> </li> </ul> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD004370.pub4/full"> Abstract </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD004370.pub4/full#pico"> PICOs </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD004370.pub4/full#CD004370-abs-0002"> Plain language summary </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD004370.pub4/full#CD004370-sec-0068"> Authors' conclusions </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD004370.pub4/full#CD004370-sec-0008"> Summary of findings </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD004370.pub4/full#CD004370-sec-0009"> Background </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD004370.pub4/full#CD004370-sec-0014"> Objectives </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD004370.pub4/full#CD004370-sec-0015"> Methods </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD004370.pub4/full#CD004370-sec-0041"> Results </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD004370.pub4/full#CD004370-sec-0062"> Discussion </a> </li> <li class="cdsr-nav-link"> <a class="figures-and-tables-link" href="/cdsr/doi/10.1002/14651858.CD004370.pub4/#"> Figures and tables </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD004370.pub4/references"> References </a> </li> </ul> <div class="nav-section-header"> <h3>Supplementary materials</h3> </div> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD004370.pub4/appendices#CD004370-sec-0073"> Search strategies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD004370.pub4/references#characteristicStudies"> Characteristics of studies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD004370.pub4/references#dataAndAnalyses"> Analyses </a> </li> <li class="cdsr-nav-link download-stats-data-link" data-download-href="/cdsr/doi/10.1002/14651858.CD004370.pub4/media/CDSR/CD004370/table_n/CD004370StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> <a href="/cdsr/doi/10.1002/14651858.CD004370.pub4/media/CDSR/CD004370/table_n/CD004370StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> Download data </a> </li> </ul> <ul class="tools-row"> <li> </li> </ul> <ul class="nav-section-header"> <li><h3>Related</h3></li> </ul> <ul class="linked-content linked-content-dropdown" id="linked-content-articles" tabindex="0"> <li class="linked-cca" data-type="cca"> <div class="linked-content-section"> <span class="linked-type">Cochrane Clinical Answers<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-editorials" data-type="editorial"> <div class="linked-content-section"> <span class="linked-type">Editorials<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-podcasts" data-type="podcast"> <div class="linked-content-section"> <span class="linked-type">Podcasts<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-sc" data-type="sc"> <div class="linked-content-section"> <span class="linked-type">Special Collections<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> </ul> <div class="nav-section-header"> <h3>About this review</h3> </div> <ul class="nav-long-form nav-info nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD004370.pub4/information"> <i> <svg viewbox="0 0 24 24"> <path d="M11,9H13V7H11M12,20C7.59,20 4,16.41 4,12C4,7.59 7.59,4 12,4C16.41,4 20,7.59 20,12C20,16.41 16.41,20 12,20M12,2A10,10 0 0,0 2,12A10,10 0 0,0 12,22A10,10 0 0,0 22,12A10,10 0 0,0 12,2M11,17H13V11H11V17Z"></path> </svg> </i> Information </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD004370.pub4/information#authors"> <i> <svg viewbox="0 0 24 24"> <path d="M12,5.5A3.5,3.5 0 0,1 15.5,9A3.5,3.5 0 0,1 12,12.5A3.5,3.5 0 0,1 8.5,9A3.5,3.5 0 0,1 12,5.5M5,8C5.56,8 6.08,8.15 6.53,8.42C6.38,9.85 6.8,11.27 7.66,12.38C7.16,13.34 6.16,14 5,14A3,3 0 0,1 2,11A3,3 0 0,1 5,8M19,8A3,3 0 0,1 22,11A3,3 0 0,1 19,14C17.84,14 16.84,13.34 16.34,12.38C17.2,11.27 17.62,9.85 17.47,8.42C17.92,8.15 18.44,8 19,8M5.5,18.25C5.5,16.18 8.41,14.5 12,14.5C15.59,14.5 18.5,16.18 18.5,18.25V20H5.5V18.25M0,20V18.5C0,17.11 1.89,15.94 4.45,15.6C3.86,16.28 3.5,17.22 3.5,18.25V20H0M24,20H20.5V18.25C20.5,17.22 20.14,16.28 19.55,15.6C22.11,15.94 24,17.11 24,18.5V20Z"></path> </svg> </i> Authors </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD004370.pub4/information#history"> <i> <svg viewbox="0 0 24 24"> <path d="M13.5,8H12V13L16.28,15.54L17,14.33L13.5,12.25V8M13,3A9,9 0 0,0 4,12H1L4.96,16.03L9,12H6A7,7 0 0,1 13,5A7,7 0 0,1 20,12A7,7 0 0,1 13,19C11.07,19 9.32,18.21 8.06,16.94L6.64,18.36C8.27,20 10.5,21 13,21A9,9 0 0,0 22,12A9,9 0 0,0 13,3"></path> </svg> </i> Version history </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD004370.pub4/information#keywords"> <i> <svg viewbox="0 0 24 24"> <path d="M11 3C10.18 3 9.44 3.5 9.14 4.27L3.64 18.27C3.12 19.58 4.09 21 5.5 21H7.75C8.59 21 9.33 20.5 9.62 19.7L10.26 18H13.74L14.38 19.7C14.67 20.5 15.42 21 16.25 21H18.5C19.91 21 20.88 19.58 20.36 18.27L14.86 4.27C14.56 3.5 13.82 3 13 3M11 5H13L18.5 19H16.25L15.12 16H8.87L7.75 19H5.5M12 7.67L9.62 14H14.37Z"></path> </svg> </i> Keywords (MeSH, PICOs) </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD004370.pub4/related-content"> <i class="icon fa fa-sitemap fa-rotate-270"></i> Related content </a> </li> <li class="cdsr-nav-link translation-notes-link"> <a href="/cdsr/doi/10.1002/14651858.CD004370.pub4/#"> <i> <svg viewbox="0 0 24 24"> <path d="M12.87,15.07L10.33,12.56L10.36,12.53C12.1,10.59 13.34,8.36 14.07,6H17V4H10V2H8V4H1V6H12.17C11.5,7.92 10.44,9.75 9,11.35C8.07,10.32 7.3,9.19 6.69,8H4.69C5.42,9.63 6.42,11.17 7.67,12.56L2.58,17.58L4,19L9,14L12.11,17.11L12.87,15.07M18.5,10H16.5L12,22H14L15.12,19H19.87L21,22H23L18.5,10M15.88,17L17.5,12.67L19.12,17H15.88Z"></path> </svg> </i> Translation notes </a> </li> <li class="cdsr-nav-link"> <a class="request-permissions" data-copyright="Copyright © 2020 The Cochrane Collaboration. Published by John Wiley &amp; Sons, Ltd." data-creative-commons="false" href="/cdsr/doi/10.1002/14651858.CD004370.pub4/#"> <span class="request-permissions-icon"></span> Request permissions </a> </li> <li class="cdsr-nav-link"> <a href="/data"> <i class="icon fa fa-database"></i> Request data reuse </a> </li> </ul> </nav> </div> <article> <div class="cdsr-header-top"> <div class="cdsr-header-left"> <a class="publish-database" href="/">Cochrane Database of Systematic reviews</a> <span class="publish-type">Review - Intervention</span> </div> <div class="cdsr-header-right"> <div class="inline-status-wrapper"> <ul class="cochrane-status"> <li aria-label="A new search for studies has been conducted." class="status-item up-to-date custom-tooltip" data-status="newsearch" title="A new search for studies has been conducted."> <a class="btn secondary" href="information#history">New search</a> </li> </ul> </div> </div> </div> <header class="publication-header"> <h1 class="publication-title" lang="en">Intravenous immunoglobulin for presumed viral myocarditis in children and adults</h1> <div class="publication-metadata-block"> <div class="publication-authors"> <div class="publish-meta-wrapper"> <ul class="authors"> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD004370.pub4/information#CD004370-cr-0004"><i class="icon corresponding-author fa fa-envelope"></i>Joan Robinson</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD004370.pub4/information#CD004370-cr-0005">Lisa Hartling</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD004370.pub4/information#CD004370-cr-0006">Ben Vandermeer</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD004370.pub4/information#CD004370-cr-0007">Meghan Sebastianski</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD004370.pub4/information#CD004370-cr-0008">Terry P Klassen</a></li> </ul> <span class="author declaration"> <a class="declarationsOfInterestLink" href="/cdsr/doi/10.1002/14651858.CD004370.pub4/information/en#CD004370-sec-0099">Authors' declarations of interest</a> </span> </div> </div> </div> <div class="publication-metadata-block"> <p> <span class="publish-date">Version published: 19 August 2020 </span> <a class="whatsNewLink" href="/cdsr/doi/10.1002/14651858.CD004370.pub4/information/en#versionTable">Version history</a> </p> <div class="doi-header"> <a href="https://doi.org/10.1002/14651858.CD004370.pub4">https://doi.org/10.1002/14651858.CD004370.pub4</a> </div> </div> </header> <div class="publication-control-bar"> <span class="publication-control-button publication-control-collapse"> Collapse all </span> <span class="publication-control-button publication-control-expand"> Expand all </span> </div> <section class="abstract"> <div class="section-header section-collapse-header" id="CD004370-abs-0001" lang="en"> <h2 class="title section-collapse-title"> Abstract <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD004370-abs-0001">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD004370-abs-0013">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD004370-abs-0011">فارسی</a> </li> <li class="section-language"> <a class="" href="full/ko#CD004370-abs-0007">한국어</a> </li> <li class="section-language"> <a class="" href="full/zh_HANS#CD004370-abs-0003">简体中文</a> </li> </nav> </div> </div> <div class="abstract full_abstract" id="CD004370-abs-0001" lang="en"> <section id="CD004370-sec-0001"> <h3 class="title" id="CD004370-sec-0001">Background</h3> <p>This is an update of a previous review. Case reports and case series have described dramatic responses to intravenous immunoglobulin (IVIG) in people with presumed viral myocarditis, and its administration has become commonplace. </p> </section> <section id="CD004370-sec-0002"> <h3 class="title" id="CD004370-sec-0002">Objectives</h3> <p>The primary objective of this review was to compare event‐free (death, requirement for a cardiac transplant, or placement of a left ventricular assist device) or overall (death) survival of adults and children with presumed viral myocarditis treated with IVIG versus those who did not receive IVIG. A secondary objective was to determine if a group of patients with presumed viral myocarditis could be identified (on the basis of age, duration of symptoms, acuity of onset of symptoms, cardiac function at presentation, virological results, or the presence or absence of histological evidence of acute myocarditis on cardiac biopsy in patients in whom a biopsy was performed) who would be the most likely to benefit from IVIG. </p> </section> <section id="CD004370-sec-0003"> <h3 class="title" id="CD004370-sec-0003">Search methods</h3> <p>We searched CENTRAL, MEDLINE, Embase, DARE, CINAHL, Web of Science Core Collection, and LILACS in July 2019, and two trial registries in November 2019. We contacted authors of trials and checked reference lists of relevant papers. We applied no language restrictions. </p> </section> <section id="CD004370-sec-0004"> <h3 class="title" id="CD004370-sec-0004">Selection criteria</h3> <p>We included studies if (1) participants had a clinical diagnosis of acute myocarditis with a left ventricular ejection fraction (LVEF) ≤ 0.45, left ventricular end‐diastolic diameter (LVEDD) &gt; 2 standard deviations (SDs) above the norm, or a left ventricular shortening fraction (LVSF) &gt; 2 SDs below the mean, with duration of cardiac symptoms &lt; 6 months; (2) participants had no evidence of non‐infectious or bacterial cardiac disease; and (3) participants were randomly assigned to receive at least 1 g/kg of IVIG versus no IVIG or placebo. </p> <p>We excluded studies if (1) participants had received immunosuppression before outcome assessment; or (2) onset of myocarditis was reported to have occurred &lt; 6 months postpartum. </p> </section> <section id="CD004370-sec-0005"> <h3 class="title" id="CD004370-sec-0005">Data collection and analysis</h3> <p>Two review authors independently screened the search results and extracted data. We assessed risk of bias with the Cochrane 'Risk of bias' tool. We conducted meta‐analysis for two outcomes (overall survival and improvement in LVEF) with two adult trials. Other meta‐analyses were not possible because only three relevant trials were included, and researchers analysed markedly different populations and used different outcome measures. </p> </section> <section id="CD004370-sec-0006"> <h3 class="title" id="CD004370-sec-0006">Main results</h3> <p>In this update we added two trials to the two previously included trials. A quasi‐randomised trial was previously included due to a paucity of evidence from randomised trials; however, with the addition of two new randomised trials, it was removed from this update. </p> <p>For two adult trials, the overall risk of bias was unclear with very low‐certainty evidence for all outcomes. The first trial studied 62 adults with recent‐onset dilated cardiomyopathy randomly assigned to receive IVIG or an equivalent volume of 0.1% albumin in a blinded fashion. The effect on event‐free survival between groups was uncertain (risk ratio (RR) of any event 1.76, 95% confidence interval (CI) 0.48 to 6.40). The second trial studied 41 adults with acute myocarditis randomised to either high‐dose IVIG (1 to 2 g/kg over two days) or no treatment. The IVIG group reported greater survival time after 60 days (no raw data, P &lt; 0.01), but the evidence is uncertain. We pooled the reported number of deaths in both trials, with no evidence of a difference between groups (RR 0.91, 95% CI 0.23 to 3.62, I<sup>2</sup> = 31%, very low‐certainty evidence). </p> <p>The evidence on the effect of IVIG treatment on LVEF (pooled mean difference (MD) −0.01, 95% CI −0.06 to 0.05) after 12 months and an unknown time frame is uncertain. The results for functional capacity, assessed by peak oxygen consumption at 12 months, were uncertain (MD −0.80, 95% CI −4.57 to 2.97). The results for infusion‐related side effects were also uncertain due to a very large CI (RR 20.29, 95% CI 1.25 to 329.93). Lastly, there was uncertain evidence addressing failure to attain complete recovery (RR 0.46, 95% CI 0.19 to 1.14).  Evidence for improvement in LVEDD, left ventricular shortening fraction, and hospitalisation status in adults was not reported.  </p> <p>In the single included paediatric trial, the overall risk of bias was low with very low‐certainty evidence for all outcomes. The trial included 86 children in Egypt presenting with acute myocarditis. Children were randomly assigned to 1 g/kg IVIG daily for two consecutive days or placebo followed by echocardiography one and six months post randomisation for recording of LVEDD and LVSF. The evidence for overall survival after six months was uncertain (risk of death RR 0.48, 95% CI 0.20 to 1.15). The evidence was also uncertain for improvement in LVEDD and LVSF after six months (LVEDD MD −4.00, 95% CI −9.52 to 1.52; LVSF no raw data).  Evidence for improvement in LVEF, functional capacity, side effects, complete recovery, and hospitalisation status in children was not reported.  </p> </section> <section id="CD004370-sec-0007"> <h3 class="title" id="CD004370-sec-0007">Authors' conclusions</h3> <p>Evidence from two trials of very low certainty and with unclear risk of bias provides contradictory evidence on the use of IVIG in the treatment of adults with presumed viral myocarditis. One trial reported that use of IVIG results in longer survival time after 60 days, whilst the other trial found that IVIG does not provide an appreciable benefit. The evidence of a difference in event‐free or overall survival, LVEDD, or LVSF is of very low certainty in a single paediatric trial with a low risk of bias. Until higher‐quality studies with low risk of bias and larger sample sizes have demonstrated benefit in a particular group of patients, the evidence for treatment with IVIG for presumed viral myocarditis is uncertain. Further studies of the pathophysiology of myocarditis would lead to improved diagnostic criteria, which would facilitate future research. </p> </section> </div> </section> <section class="pico-section" id="pico"> <h2 class="title section-collapse-title">PICOs <i class="icon fa fa-info-circle" title="The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome."></i> <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-content" style="display: block;"> <h3 class="keyword-heading">PICOs</h3> <div class="pico-table"> <div class="pico-column Population"> <h6>Population<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Intervention"> <h6>Intervention<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Comparison"> <h6>Comparison<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Outcome"> <h6>Outcome<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> </div> <div class="pico-information"> <p><i class="icon fa fa-info-circle"></i> The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome.</p> <p>See more on using PICO in the <a href="https://training.cochrane.org/handbook/current/chapter-02#section-2-3">Cochrane Handbook</a>.</p> </div> </div> </section> <section class="pls"> <div class="section-header section-collapse-header" id="CD004370-abs-0002" lang="en"> <h2 class="title section-collapse-title"> Plain language summary <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD004370-abs-0002">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD004370-abs-0014">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD004370-abs-0012">فارسی</a> </li> <li class="section-language"> <a class="" href="full/hr#CD004370-abs-0010">Hrvatski</a> </li> <li class="section-language"> <a class="" href="full/ko#CD004370-abs-0008">한국어</a> </li> <li class="section-language"> <a class="" href="full/ms#CD004370-abs-0009">Bahasa Malaysia</a> </li> <li class="section-language"> <a class="" href="full/ru#CD004370-abs-0006">Русский</a> </li> <li class="section-language"> <a class="" href="full/zh_HANS#CD004370-abs-0004">简体中文</a> </li> <li class="section-language"> <a class="" href="full/zh_HANT#CD004370-abs-0005">繁體中文</a> </li> </nav> </div> </div> <div class="abstract abstract_plainLanguageSummary" id="CD004370-abs-0002" lang="en"> <h3>Intravenous immunoglobulin for presumed viral myocarditis in children and adults</h3> <p><b>Background</b> </p> <p>Acute myocarditis is inflammation of the heart and is thought to most commonly begin as a viral infection. The disease affects individuals of all ages. On the basis of multiple case reports and case series, intravenous immunoglobulin (IVIG) has become part of routine practice for treating adults and children with acute myocarditis at many centres. </p> <p><b>Results</b> </p> <p>This is the second update of a previous review, which found one randomised controlled trial (RCT) (a type of study in which participants are assigned to one of two or more treatment groups using a random method) of 62 adults, which suggested that IVIG is not useful in myocarditis. The evidence in this update is current to 2 July 2019, at which point two studies were added: one RCT of 86 children did not find any evidence that IVIG increases survival over placebo, and one RCT of 41 adults did not find evidence of increased survival (less mortality), but did report that patients lived longer for the group treated with IVIG compared to the untreated group. After pooling the available data, there was uncertain evidence of the effect of IVIG in preventing deaths. More RCT evidence is required before IVIG can be routinely recommended for adults or children with myocarditis. </p> </div> </section> <section id="vls" style="display: none"> <div class="section-header section-collapse-header"> <h2 class="title section-collapse-title">Visual summary<i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i></h2> </div> <a href="" target="_blank"><img alt="visual summary" src=""/></a> </section> <section class="conclusions"> <div class="section-header section-collapse-header" id="CD004370-sec-0068" lang="en"> <h2 class="title section-collapse-title"> Authors' conclusions <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="authorsConclusions" lang="en"> <div class="section-header" id="CD004370-sec-0068"></div> <h3 class="title" id="CD004370-sec-0069">Implications for practice</h3> <section id="CD004370-sec-0069"> <p>Evidence from two trials involving 103 adults provides incongruent evidence regarding the use of intravenous immunoglobulin (IVIG) for the management of presumed viral myocarditis in adults. In both studies, it is unknown whether all participants had viral myocarditis, as this was usually a clinical rather than a biopsy‐proven diagnosis (<a href="./references#CD004370-bbs2-0002" title="KishimotoC , ShiojiK , HashimotoT , NonogiH , LeeJD , KatoS , et al. Therapy with immunoglobulin in patients with acute myocarditis and cardiomyopathy: analysis of leukocyte balance. Heart Vessels2014;29:336-42. ">Kishimoto 2014</a>; <a href="./references#CD004370-bbs2-0003" title="McNamaraDM , HolubkovR , StarlingRC , DecGW , LohE , Torre-AmioneG , et al. Controlled trial of intravenous immune globulin in recent-onset dilated cardiomyopathy. Circulation2001;103(18):2254-9. McNamaraDM , StarlingRC , DecGW , LohE , Torre-AmioneG , GassA , et al. Intervention in myocarditis and acute cardiomyopathy with immune globulin: results from the randomized placebo controlled IMAC trial. Circulation1999;100(18):104. ">McNamara 2001</a>). One of the adult trials did report longer survival time in the first 60 days with a tendency towards longer total survival, but did not detail randomisation methods (<a href="./references#CD004370-bbs2-0002" title="KishimotoC , ShiojiK , HashimotoT , NonogiH , LeeJD , KatoS , et al. Therapy with immunoglobulin in patients with acute myocarditis and cardiomyopathy: analysis of leukocyte balance. Heart Vessels2014;29:336-42. ">Kishimoto 2014</a>). Pooled data showed the risk of death in these two studies to be not significant, with both harm and benefit. Evidence from a single paediatric trial was also inconclusive. The study of 86 children found that IVIG favoured but did not significantly improve survival (<a href="./references#CD004370-bbs2-0001" title="El-SaiediSA . Randomized controlled trial on the use of intravenous immune globulin in acute pediatric myocarditis. Journal of Clinical Research &amp; Bioethics2013;5(1):1-5. ">El‐Saiedi 2013</a>). Further randomised controlled trials are needed. Until higher‐quality studies demonstrate benefit in a particular group of patients, the evidence for treatment with IVIG for presumed viral myocarditis is uncertain. </p> </section> <h3 class="title" id="CD004370-sec-0070">Implications for research</h3> <section id="CD004370-sec-0070"> <p>The greatest need is for further studies of the pathophysiology of acute myocarditis, which would provide a better understanding of the aetiology and natural history of the disease. This might lead to improved diagnostic criteria, which would make it much easier for researchers to design studies of treatment options. This might also lead to recognition of subgroups of patients for whom IVIG has greater potential to confer clinical benefit. </p> </section> </section> </section> <section class="summaryOfFindings"> <div class="section-header section-collapse-header" id="CD004370-sec-0008" lang="en"> <h2 class="title section-collapse-title"> Summary of findings <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="summaryOfFindings" lang="en"> <div class="section-header" id="CD004370-sec-0008"></div> <div class="table" id="CD004370-tbl-0001"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings 1.</span> <span class="table-title">Intravenous immunoglobulin compared with placebo or no treatment for adults with acute myocarditis</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Intravenous immunoglobulin compared with placebo or no treatment for adults with acute myocarditis</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Patient or population:</b> adults with acute myocarditis </p> <p><b>Settings:</b> hospital </p> <p><b>Intervention:</b> IVIG </p> <p><b>Comparison:</b> placebo or no treatment </p> </td> </tr> <tr class="separated"> <th align="left" class="headercell" colspan="1" rowspan="3" scope="col" valign="bottom"> <p><b>Outcomes</b> </p> </th> <th align="left" class="headercell table-tint" colspan="2" rowspan="1" scope="col" valign="bottom"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="3" scope="col" valign="bottom"> <p><b>Relative effect<br/>(95% CI)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="3" scope="col" valign="bottom"> <p><b>Number of participants<br/>(studies)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="3" scope="col" valign="bottom"> <p><b>Certainty of the evidence<br/>(GRADE)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="3" scope="col" valign="bottom"> <p><b>Comments</b> </p> </th> </tr> <tr class="separated"> <th align="left" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Assumed risk</b> </p> </th> <th align="left" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Corresponding risk</b> </p> </th> </tr> <tr class="separated"> <th align="left" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Control</b> </p> </th> <th align="left" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>IVIG</b> </p> </th> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Event‐free survival (risk of death, cardiac transplant, or left ventricular assist device) ‐ adults with myocarditis, median follow‐up of 23 months </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>103 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>182 per 1000</p> <p>(50 to 662)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>RR 1.76 (0.48 to 6.40)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>62 (1)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/><b>Very low</b><sup>1,2,3</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Overall survival (risk of death) ‐ adults with myocarditis, median follow‐up of 3.5 months </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>182 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>165 per 1000</p> <p>(42 to 658)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>RR 0.91 (0.23 to 3.62)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>103 (2)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/><b>Very low</b><sup>1,3,4</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Side effects ‐ mild infusion effects, 12‐month follow‐up</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>0 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>2 per 1000</p> <p>(0 to 33)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>RR 20.29 (1.25 to 329.93)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>62 (1)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝</p> <p><b>Very low</b><sup>1,5,6</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No control participants reported side effects; baseline risk was estimated to be 0.01% based on the limited data available. For the data reported NNTH = 3. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*Basis for assumed risk was calculated by the number of events in the control group reported for each survival outcome. For side effects, no events were reported in the control group. To estimate baseline risk we assumed a low baseline risk of 0.01% based on the limited data available for that outcome. The <b>corresponding risk</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI). </p> <p><b>CI:</b> confidence interval; <b>IVIG:</b> intravenous immunoglobulin; <b>NNTH</b> : number needed to treat for an additional harmful outcome; <b>RR:</b> risk ratio </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/><b>High certainty:</b> Further research is very unlikely to change our confidence in the estimate of effect.<br/><b>Moderate certainty:</b> Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.<br/><b>Low certainty:</b> Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.<br/><b>Very low certainty:</b> We are very uncertain about the estimate. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup>Downgraded by 1 level due to unclear risk of bias related to lack of clarity around randomisation and blinding.<br/><sup>2</sup>Downgraded by 1 level for indirectness as very few participants had proven myocarditis.<br/><sup>3</sup>Downgraded by 2 levels for imprecision due to optimal information size not being met and CI including both appreciable benefit and harm.<br/><sup>4</sup>Downgraded by 1 level for indirectness as it was it was unclear if biopsies were done to confirm myocarditis and rule out congential cardiomyopathies.<br/><sup>5</sup>Downgraded by 1 level for indirectness due to uncertainty of the baseline estimate.<br/><sup>6</sup>Downgraded by 1 level for imprecision due to optimal information size not being met and large CI. </p> </div> </td> </tr> </tfoot> </table> </div> <div class="table" id="CD004370-tbl-0002"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings 2.</span> <span class="table-title">Intravenous immunoglobulin compared with placebo or no treatment for children with acute myocarditis</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p><b>Intravenous immunoglobulin compared with placebo or no treatment for children with acute myocarditis</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p><b>Patient or population:</b> children with acute myocarditis </p> <p><b>Settings:</b> hospital </p> <p><b>Intervention:</b> IVIG </p> <p><b>Comparison:</b> placebo or no treatment </p> </td> </tr> <tr class="separated"> <th align="left" class="headercell" colspan="1" rowspan="3" scope="col" valign="bottom"> <p><b>Outcomes</b> </p> </th> <th align="left" class="headercell table-tint" colspan="2" rowspan="1" scope="col" valign="bottom"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="3" scope="col" valign="bottom"> <p><b>Relative effect<br/>(95% CI)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="3" scope="col" valign="bottom"> <p><b>Number of participants<br/>(studies)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="3" scope="col" valign="bottom"> <p><b>Certainty of the evidence<br/>(GRADE)</b> </p> </th> </tr> <tr class="separated"> <th align="left" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Assumed risk</b> </p> </th> <th align="left" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Corresponding risk</b> </p> </th> </tr> <tr class="separated"> <th align="left" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Control</b> </p> </th> <th align="left" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>IVIG</b> </p> </th> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Overall survival (risk of death) ‐ children with myocarditis, 6‐month follow‐up</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>295 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>142 per 1000</p> <p>(59 to 340)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>RR 0.48 (0.20 to 1.15)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>86 (1)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/><b>Very low</b><sup>1,2</sup> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p>*Basis for assumed risk was calculated by the number of events in the control group reported for each survival outcome. The <b>corresponding risk</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI). </p> <p><b>CI:</b> confidence interval; <b>IVIG:</b> intravenous immunoglobulin; <b>RR:</b> risk ratio </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/><b>High certainty:</b> Further research is very unlikely to change our confidence in the estimate of effect.<br/><b>Moderate certainty:</b> Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.<br/><b>Low certainty:</b> Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.<br/><b>Very low certainty:</b> We are very uncertain about the estimate. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="6"> <div class="table-footnote"> <p><sup>1</sup>Downgraded by 2 levels for imprecision due to optimal information size not being met and CI including both appreciable benefit and harm.<br/><sup>2</sup>Downgraded by 1 level for indirectness as it was it was unclear if biopsies were done to confirm myocarditis and rule out congential cardiomyopathies. </p> </div> </td> </tr> </tfoot> </table> </div> </section> </section> <section class="background"> <div class="section-header section-collapse-header" id="CD004370-sec-0009" lang="en"> <h2 class="title section-collapse-title"> Background <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="background" lang="en"> <div class="section-header" id="CD004370-sec-0009"></div> <section id="CD004370-sec-0010"> <h3 class="title" id="CD004370-sec-0010">Description of the condition</h3> <p>Acute myocarditis is a disease that occurs in individuals of all ages. It is presumed to usually start as a viral infection, although autoimmune and idiopathic forms also occur. It remains unclear whether the primary problem is most commonly ongoing damage from a virus, a postinfectious inflammatory reaction, or a combination of the two. </p> <p>One problem involved in analysing the literature on the treatment of patients with acute myocarditis is that the enrolment criteria for these studies are far from uniform. Reasons for this include the following. </p> <p> <ul id="CD004370-list-0001"> <li> <p>No reference standard has been accepted for the diagnosis of acute myocarditis. Detection of pathogens from cardiac tissue would represent evidence in favour of infectious myocarditis. This seldom occurs, presumably because the concentration of pathogens is typically very low by the time a biopsy is performed. The yield is improved by molecular techniques (<a href="./references#CD004370-bbs2-0038" title="GuglinM , NallamshettyL . Myocarditis: diagnosis and treatment. Current Treatment Options in Cardiovascular Medicine2012;14(6):637-51.">Guglin 2012</a>). However, it is not clear whether detection of latent viruses such as cytomegalovirus in cardiac tissue is always indicative of myocarditis. It has been suggested that one way to diagnose acute myocarditis is to perform cardiac biopsies at a minimum of five sites to look for histology fulfilling the Dallas criteria. These criteria require evidence of lymphocytic infiltration and myocyte necrosis with or without degeneration (<a href="./references#CD004370-bbs2-0057" title="TowbinJ . Myocarditis and pericarditis in adolescents. Adolescent Medicine2001;12(1):47-67.">Towbin 2001</a>). However, studies have shown that biopsies on about half of adults with acute myocarditis at autopsy did not fulfil the Dallas criteria (<a href="./references#CD004370-bbs2-0057" title="TowbinJ . Myocarditis and pericarditis in adolescents. Adolescent Medicine2001;12(1):47-67.">Towbin 2001</a>). The reason for this is that inflammation can be patchy or transient, and can progress to fibrosis (which would not be interpreted as acute myocarditis) (<a href="./references#CD004370-bbs2-0044" title="LeviD , AlejosJ . Diagnosis and treatment of pediatric viral myocarditis. Current Opinion in Cardiology2001;16(2):77-83.">Levi 2001</a>). Consequently, many studies include patients who do not fulfil the Dallas criteria for acute myocarditis. Alternative World Heart Federation criteria require a diffuse, focal or confluent infiltrate of ≥ 14 leucocytes/mm<sup>2</sup> (primarily lymphocytes with up to 4 macrophages/mm<sup>2</sup> permitted) (<a href="./references#CD004370-bbs2-0048" title="MaischB , RisticAD , HufnagelG , FunckR , AlterP , TontschD , et al. Dilated cardiomyopathies as a cause of congestive heart failure. Herz2002;27(2):113-34.">Maisch 2002</a>; <a href="./references#CD004370-bbs2-0049" title="MaischB , PankuweitS . Standard and etiology-directed evidence-based therapies in myocarditis: state of the art and future perspectives. Heart Failure Reviews2013;18(6):761-95.">Maisch 2013</a>; <a href="./references#CD004370-bbs2-0051" title="MeyerT , GrumbachIM , KreuzerH , MorguetAJ . Giant cell myocarditis due to coxsackie B2 virus infection. Cardiology1997;88(3):296-9.">Meyer 1997</a>). Progress has been reported in the use of diagnostic imaging for diagnosis of acute myocarditis. The 'Lake Louise criteria' can be applied to cardiac magnetic resonance imaging (MRI) for the diagnosis of acute myocarditis (<a href="./references#CD004370-bbs2-0036" title="FriedrichMG , SechtemU , Schulz-MengerJ , HolmvangG , AlakijaP , CooperLT , et al. Cardiovascular magnetic resonance in myocarditis: a JACC white paper. Journal of the American College of Cardiology2009;53(17):1475-87.">Friedrich 2009</a>). As with an endomyocardial biopsy, the sensitivity of cardiac MRI is greatest if performed early in the course of myocarditis. MRI cannot distinguish viral from other forms of acute myocarditis, but MRI‐guided biopsies have a higher yield than blinded biopsies (<a href="./references#CD004370-bbs2-0038" title="GuglinM , NallamshettyL . Myocarditis: diagnosis and treatment. Current Treatment Options in Cardiovascular Medicine2012;14(6):637-51.">Guglin 2012</a>). </p> </li> <li> <p>The nomenclature of myocarditis is not yet standardised. For example, the term 'acute myocarditis' is used by some study authors to refer to all cases of active myocarditis (<a href="./references#CD004370-bbs2-0037" title="FuseK , KodamaM , OkuraY . Predictors of disease course in patients with acute myocarditis. Circulation2000;102(23):2829-35.">Fuse 2000</a>), whereas other study authors use the term only for disease of indistinct onset, using the term 'fulminant' for cases with a distinct onset and clear evidence of a recent viral illness (<a href="./references#CD004370-bbs2-0039" title="HareJM , BaughmanKL . Fulminant and acute myocarditis: the prognostic value of clinicopathological classification. European Heart Journal2001;22(4):269-70.">Hare 2001</a>). Some study authors use the term 'acute myocarditis' for a presumed infectious process, but others include non‐infectious entities. Some experts believe that infectious myocarditis progresses from a phase where viral infection dominates to a phase where autoimmunity dominates (<a href="./references#CD004370-bbs2-0045" title="LiuPP , MasonJW . Advances in the understanding of myocarditis. Circulation2001;104(9):1076-82.">Liu 2001</a>). If viral replication or cytokine production persists, the patient develops a dilated cardiomyopathy (<a href="./references#CD004370-bbs2-0045" title="LiuPP , MasonJW . Advances in the understanding of myocarditis. Circulation2001;104(9):1076-82.">Liu 2001</a>). If viral replication and cytokine production cease, the patient spontaneously recovers. An alternate viewpoint is that the disease begins as rapidly progressive, acute, or chronic myocarditis, and that these three presentations are not part of a continuum (<a href="./references#CD004370-bbs2-0034" title="FenoglioJJ , UrsellPC , KelloggCF , DrusinRE , WeissMB . Diagnosis and classification of myocarditis by endomyocardial biopsy. New England Journal of Medicine1983;308(1):12-8.">Fenoglio 1983</a>). Because no agreement has been reached on the natural history of acute myocarditis, and no uniform classification scheme has been devised, it is not possible for studies to consistently report results of treatment for different types of myocarditis. </p> </li> <li> <p>No consensus has been reached regarding which investigations must be done to exclude non‐infectious causes of acute myocardial dysfunction. In previously well paediatric patients, a clinical diagnosis of infectious myocarditis is fairly accurate, although congenital cardiomyopathy can present acutely. In adults, ischaemic heart disease is commonly confused with viral myocarditis. Other causes of acute cardiac dysfunction include drug‐induced dysfunction (from alcohol, organic solvents, cocaine, or chemotherapeutic or cardiac agents), collagen vascular disease, and postpartum cardiomyopathy. </p> </li> </ul> </p> <p>It is not clear how acute myocarditis in children differs from acute myocarditis in adults. However, one study showed that 17 of 18 adults with fulminant myocarditis survived (<a href="./references#CD004370-bbs2-0050" title="McCarthyRE , BoehmerJP , HrubanRH , HutchinsGM , KasperEK , HareJM , et al. Long-term outcome of fulminant myocarditis as compared with acute (non-fulminant) myocarditis. New Engand Journal of Medicine2000;342(10):690-5.">McCarthy 2000</a>), whereas a paediatric study described survival in only two of nine infants with fulminant myocarditis (<a href="./references#CD004370-bbs2-0052" title="MountsAW , AmrS , JamshidiR , GrovesC , DwyerD , GuarnerJ , et al. A cluster of fulminant myocarditis cases in children, Baltimore, Maryland, 1997. Pediatric Cardiology2001;22(1):34-9.">Mounts 2001</a>). </p> </section> <section id="CD004370-sec-0011"> <h3 class="title" id="CD004370-sec-0011">Description of the intervention</h3> <p>Intravenous immunoglobulin (IVIG) is a pooled blood product that contains a mix of antibodies taken from the blood of healthy donors. It is a type of immunotherapy. </p> </section> <section id="CD004370-sec-0012"> <h3 class="title" id="CD004370-sec-0012">How the intervention might work</h3> <p>If ongoing infection is the primary problem, IVIG could be efficacious if it contains antibodies to the microbe. IVIG also has anti‐inflammatory properties, so it could be efficacious even if the primary problem is a postinfectious inflammatory reaction or a non‐infectious process. </p> </section> <section id="CD004370-sec-0013"> <h3 class="title" id="CD004370-sec-0013">Why it is important to do this review</h3> <p>Multiple case reports, <a href="./references#CD004370-bbs2-0053" title="NigroG , BastianonV , ColloridiV , VentrigliaF , GalloP , D'AmatiG , et al. Human parvovirus B19 infection in infancy associated with acute and chronic lymphocyte myocarditis and high cytokine levels: report of 3 cases and review. Clinical Infectious Diseases2001;31(1):65-9.">Nigro 2001</a>; <a href="./references#CD004370-bbs2-0055" title="TakedaY , YasudaS , MiyazakiS , DaikokuS , NakataniS , NonogiH . High-dose immunoglobulin G therapy for fulminant myocarditis. Japanese Circulation Journal1998;62(11):871-2.">Takeda 1998</a>; <a href="./references#CD004370-bbs2-0056" title="TedeschiA , GianniniS , CiceriL , MassariFM . High-dose intravenous immunoglobulin in the treatment of acute myocarditis. A case report and review of the literature. Journal of Internal Medicine2002;251(2):169-73.">Tedeschi 2002</a>, and case series, <a href="./references#CD004370-bbs2-0004" title="AlrabteSAH , BezantiK . Role of intravenous immunoglobulin in the treatment of acute myocarditis. Cardiology in the Young2013;2013:S96. ">Alrabate 2013</a>; <a href="./references#CD004370-bbs2-0012" title="DruckerNA , ColanSD , LewisAB , BeiserAS , WesselDL , TakahashiM , et al. Gamma-globulin treatment of acute myocarditis in the pediatric population. Circulation1994;89(1):252-7. ">Drucker 1994</a>; <a href="./references#CD004370-bbs2-0014" title="GolandS , CzerLS , SiegelRJ , TabakS , JordanS , LuthringerD , et al. Intravenous immunoglobulin treatment for acute fulminant cardiomyopathy: series of six patients and review of literature. Canadian Journal of Cardiology2008;24(7):571-4. ">Goland 2008</a>; <a href="./references#CD004370-bbs2-0016" title="HaqueA , BhattiS , SiddiquiFJ . Intravenous immune globulin for severe acute myocarditis in children. Indian Pediatrics2009;46(9):810-1. ">Haque 2009</a>, have described apparent dramatic responses to IVIG in adults and children with acute myocarditis, with one large case series suggesting no benefit irrespective of severity of illness (<a href="./references#CD004370-bbs2-0018" title="KlugmanD , BergerJT , SableCA , HeJ , KhandelwalSG , SlonimAD . Pediatric patients hospitalized with myocarditis: a multi-institutional analysis. Pediatric Cardiology2009;31(2):222-8. ">Klugman 2009</a>). However, results from a randomised controlled trial showed no advantage in IVIG‐treated adults with recent‐onset dilated cardiomyopathy (or in the subgroup with histological evidence of acute myocarditis) (<a href="./references#CD004370-bbs2-0003" title="McNamaraDM , HolubkovR , StarlingRC , DecGW , LohE , Torre-AmioneG , et al. Controlled trial of intravenous immune globulin in recent-onset dilated cardiomyopathy. Circulation2001;103(18):2254-9. McNamaraDM , StarlingRC , DecGW , LohE , Torre-AmioneG , GassA , et al. Intervention in myocarditis and acute cardiomyopathy with immune globulin: results from the randomized placebo controlled IMAC trial. Circulation1999;100(18):104. ">McNamara 2001</a>). </p> </section> </section> </section> <section class="objectives"> <div class="section-header section-collapse-header" id="CD004370-sec-0014" lang="en"> <h2 class="title section-collapse-title"> Objectives <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="objectives" lang="en"> <div class="section-header" id="CD004370-sec-0014"></div> <p>The primary objective of this review was to compare event‐free (death, requirement for a cardiac transplant, or placement of a left ventricular assist device) or overall (death) survival of adults and children with presumed viral myocarditis treated with IVIG versus those who did not receive IVIG. A secondary objective was to determine if a group of patients with presumed viral myocarditis could be identified (on the basis of age, duration of symptoms, acuity of onset of symptoms, cardiac function at presentation, virological results, or the presence or absence of histological evidence of acute myocarditis on cardiac biopsy in patients in whom a biopsy was performed) who would be the most likely to benefit from IVIG. </p> </section> </section> <section class="methods"> <div class="section-header section-collapse-header" id="CD004370-sec-0015" lang="en"> <h2 class="title section-collapse-title"> Methods <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="methods" lang="en"> <div class="section-header" id="CD004370-sec-0015"></div> <section id="CD004370-sec-0016"> <h3 class="title">Criteria for considering studies for this review</h3> <section id="CD004370-sec-0017"> <h4 class="title">Types of studies</h4> <p>This review included randomised controlled trials (RCTs) that compared study participants treated with IVIG versus participants who did not receive IVIG. </p> <p>We did not include trials that compared IVIG versus immunosuppressive therapy, as tremendous variability has been noted in the type and dose of immunosuppressive drugs used and in the timing of administration of these drugs. However, if arms of a trial included an IVIG group and a placebo or no‐therapy group, participants from these arms were considered for inclusion in this review if possible. </p> </section> <section id="CD004370-sec-0018"> <h4 class="title">Types of participants</h4> <section id="CD004370-sec-0019"> <h5 class="title">Inclusion criteria</h5> <p>We included inpatients and outpatients of any age, sex, or race.</p> <p> <ul id="CD004370-list-0002"> <li> <p>Participants had to have a clinical diagnosis of acute myocarditis and at least one of the following: </p> </li> </ul> </p> <p> <ul class="plain" id="CD004370-list-0003"> <li> <ul id="CD004370-list-0004"> <li> <p>left ventricular ejection fraction (LVEF) ≤ 0.45;</p> </li> <li> <p>left ventricular end‐diastolic diameter (LVEDD) &gt; 2 standard deviations (SDs) above the norm as adjusted for body surface area; </p> </li> <li> <p>left ventricular shortening fraction (LVSF) &gt; 2 SDs less than the mean as adjusted for age, or &lt; 29% in an adult. </p> </li> </ul> </li> </ul> </p> <p> <ul id="CD004370-list-0005"> <li> <p>The duration of cardiac symptoms before randomisation had to be &lt; 6 months.</p> </li> </ul> </p> <p>As a result of the poor sensitivity of cardiac biopsy as a diagnostic tool for acute myocarditis, and the fact that biopsies are seldom performed in children with suspected myocarditis, a histological diagnosis was not required. </p> </section> <section id="CD004370-sec-0020"> <h5 class="title">Exclusion criteria</h5> <p> <ul id="CD004370-list-0006"> <li> <p>Participants could not have any evidence of non‐infectious or bacterial cardiac disease.</p> </li> <li> <p>Studies that included participants who had received immunosuppression before the final assessment of outcome following IVIG/no IVIG were excluded, as the benefit of immunosuppression remains controversial. </p> </li> <li> <p>As the pathogenesis of postpartum cardiomyopathy is likely to differ from that of other cases of acute myocarditis, participants were excluded if onset of myocarditis was reported to be less than six months postpartum. </p> </li> </ul> </p> </section> </section> <section id="CD004370-sec-0021"> <h4 class="title">Types of interventions</h4> <p>Standard therapy for myocarditis is supportive care. In addition to this, participants must have been randomly assigned to receive at least 1 g/kg of any standard formulation of IVIG versus either placebo or no additional therapy. </p> </section> <section id="CD004370-sec-0022"> <h4 class="title">Types of outcome measures</h4> <p>We planned to analyse outcome measures using the longest follow‐up time reported for each study. We planned to analyse all outcome measures separately in the subgroup of participants who had cardiac biopsies that fulfilled the Dallas or World Heart Federation criteria for acute myocarditis (<a href="./references#CD004370-bbs2-0033" title="AretzHT . Myocarditis: the Dallas criteria. Human Pathology1987;18:619-24.">Aretz 1987</a>; <a href="./references#CD004370-bbs2-0046" title="MaischB , BültmannB , FactorS , GroeneHJ , HufnagelG , KawarmuraK , et al. World Heart Federation consensus conferences's definition of inflammatory cardiomyopathy (myocarditis): report from two expert committees on histology and viral cardiomyopathy. Heartbeat1999;4:3-4.">Maisch 1999</a>; <a href="./references#CD004370-bbs2-0047" title="MaischB , PortigI , RisticA , HufnagelG , PankuweitS . Definition of inflammatory cardiomyopathy (myocarditis): on the way to consensus. Herz2000;25:200-9.">Maisch 2000</a>). </p> <p>Reporting one or more of the outcomes listed here was not an inclusion criterion for the review. Where a published report did not appear to report one of these outcomes, we accessed the trial protocol and attempted to contact the trial authors to ascertain whether the outcomes were measured but not reported. Relevant trials that measured these outcomes but reported no data at all, or data not in a useable format, were included in the review as part of the narrative. </p> <section id="CD004370-sec-0023"> <h5 class="title">Primary outcomes</h5> <p> <ul id="CD004370-list-0007"> <li> <p>Event‐free survival, measured as risk of death or the requirement for cardiac transplant or placement of a left ventricular assist device. </p> </li> <li> <p>Overall survival, measured as risk of death.</p> </li> </ul> </p> </section> <section id="CD004370-sec-0024"> <h5 class="title">Secondary outcomes</h5> <p> <ul id="CD004370-list-0008"> <li> <p>Improvement in LVEF. We planned to examine change from baseline and look for the presence or absence of normalisation. </p> </li> <li> <p>Improvement in LVEDD. We planned to examine change from baseline and look for the presence or absence of normalisation. </p> </li> <li> <p>Improvement in LVSF. We planned to examine change from baseline and look for the presence or absence of normalisation. </p> </li> <li> <p>Improvement in functional capacity (as determined by increased exercise tolerance as measured by any objective test and the New York Heart Association Functional Capacity test). </p> </li> <li> <p>Occurrence of side effects.</p> </li> <li> <p>Failure to attain complete recovery.</p> </li> <li> <p>Hospitalisation status.</p> </li> </ul> </p> </section> </section> </section> <section id="CD004370-sec-0025"> <h3 class="title">Search methods for identification of studies</h3> <section id="CD004370-sec-0026"> <h4 class="title">Electronic searches</h4> <p>We re‐ran search strategies from the previous searches in 2009 (<a href="./appendices#CD004370-sec-0074">Appendix 1</a>) and 2014 (<a href="./appendices#CD004370-sec-0080">Appendix 2</a>) on 2 July 2019 (<a href="./appendices#CD004370-sec-0087">Appendix 3</a>). We searched the Cochrane Central Register of Controlled Trials (CENTRAL) (via CRS Web) and the Database of Abstracts of Reviews of Effects (DARE) (2015, Issue 2 of 4: last issue available), MEDLINE and Epub Ahead of Print, In‐Process &amp; Other Non‐Indexed Citations and Daily (Ovid, 1946 to 27 June 2019), Embase (Ovid, 1980 to Week 26 2019), the Cumulative Index to Nursing and Allied Health Literature (CINAHL) (EBSCO, 1937 to 2 July 2019), Web of Science Core Collection (Thomson Reuters, 1900 to 2 July 2019), and the Latin American and Caribbean Health Science Information database (LILACS) (BIREME, 1982 to 2 July 2019). </p> <p>The Cochrane sensitivity‐maximising RCT filter was applied to MEDLINE; for Embase, terms as recommended in the Cochrane Handbook were applied (<a href="./references#CD004370-bbs2-0043" title="LefebvreC , ManheimerE , GlanvilleJ . Chapter 6: Searching for studies. In: Higgins JP, Green S, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available at handbook.cochrane.org.">Lefebvre 2011</a>). An adaptation of the RCT filter was applied to all other databases, except CENTRAL and DARE. </p> <p>We did not limit the search by language or publication status, and included all years available for each database. </p> </section> <section id="CD004370-sec-0027"> <h4 class="title">Searching other resources</h4> <p>We reviewed the reference lists of all included studies for further studies.</p> <p>We searched the following clinical trial registers in January 2014:</p> <p> <ul id="CD004370-list-0009"> <li> <p>National Heart, Lung, and Blood Institute (<a href="http://www.nhlbi.nih.gov/index.htm" target="_blank">www.nhlbi.nih.gov/index.htm</a>); </p> </li> <li> <p>ISRCTN Register (<a href="http://www.controlled-trials.com/" target="_blank">www.controlled-trials.com</a>); </p> </li> <li> <p>Clinicaltrials.gov (<a href="http://clinicaltrials.gov/" target="_blank">clinicaltrials.gov</a>); </p> </li> <li> <p>National Research Register Archive and National Institute for Health Research (NIHR) Portfolio Database (<a href="https://portal.nihr.ac.uk/" target="_blank">portal.nihr.ac.uk</a>); </p> </li> <li> <p>CenterWatch (<a href="http://www.centerwatch.com/search.asp" target="_blank">www.centerwatch.com/search.asp</a>); </p> </li> <li> <p>CardioSource (<a href="http://www.cardiosource.com/" target="_blank">www.cardiosource.com</a>); </p> </li> <li> <p><a href="http://www.neri.org/html/research/clinical/pediatric.asp" target="_blank">www.neri.org/html/research/clinical/pediatric.asp</a> (to 2003). </p> </li> </ul> </p> <p>For this update we searched the following clinical trial registers on 4 November 2019:</p> <p> <ul id="CD004370-list-0010"> <li> <p>US National Institutes of Health Ongoing Trials Register ClinicalTrials.gov (<a href="http://clinicaltrials.gov" target="_blank">clinicaltrials.gov</a>); </p> </li> <li> <p>World Health Organization International Clinical Trials Registry Platform (WHO ICTRP) (<a href="https://www.who.int/ictrp/en/" target="_blank">www.who.int/ictrp/en/</a>). </p> </li> </ul> </p> </section> </section> <section id="CD004370-sec-0028"> <h3 class="title" id="CD004370-sec-0028">Data collection and analysis</h3> <section id="CD004370-sec-0029"> <h4 class="title">Selection of studies</h4> <p>Two review authors (JR, MS) independently examined the titles and abstracts of trials generated by the search to identify those that were potentially relevant. We obtained the full‐texts of those studies deemed potentially relevant, and two review authors (JR, MS) assessed these for inclusion in the review using a standardised form. We planned to resolve any discrepancies through discussion. </p> </section> <section id="CD004370-sec-0030"> <h4 class="title">Data extraction and management</h4> <p>Two review authors (JR, MS) independently extracted data using a standard data form to capture the following information. </p> <p> <ul id="CD004370-list-0011"> <li> <p>Study characteristics (e.g. design, quality, funding source).</p> </li> <li> <p>Study participants (e.g. age, severity of illness, duration of symptoms, number of participants randomised, followed up, and analysed). </p> </li> <li> <p>Intervention (e.g. dose of IVIG).</p> </li> <li> <p>Outcome measures (e.g. event‐free survival, overall survival, LVEF, LVEDD, LVSF, functional capacity, side effects, complete recovery, hospitalisation status). </p> </li> <li> <p>Results.</p> </li> </ul> </p> <p>We noted no discrepancies in data extraction. We requested additional unpublished data from the primary author of one included trial (<a href="./references#CD004370-bbs2-0024" title="McNamaraDM , RosenblumWD , JanoskoKM , TrostMK , VillaneuvaFS , DemetrisAJ , et al. Intravenous immune globulin in the therapy of myocarditis and acute cardiomyopathy. Circulation1997;95(11):2476-8. ">McNamara 1997</a>). </p> </section> <section id="CD004370-sec-0031"> <h4 class="title">Assessment of risk of bias in included studies</h4> <p>Two review authors (JR, MS) independently assessed all included studies using the Cochrane 'Risk of bias' tool (<a href="./references#CD004370-bbs2-0040" title="HigginsJP , GreenS , editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available at handbook.cochrane.org.">Higgins 2011</a>). We determined overall risk of bias based on the primary outcome (event‐free survival or overall survival) within each study. We assessed the risk of bias according to the following seven domains: </p> <p> <ul id="CD004370-list-0012"> <li> <p>random sequence generation;</p> </li> <li> <p>allocation concealment;</p> </li> <li> <p>blinding of participants and personnel;</p> </li> <li> <p>blinding of outcome assessment;</p> </li> <li> <p>incomplete outcome data;</p> </li> <li> <p>selective outcome reporting;</p> </li> <li> <p>other bias.</p> </li> </ul> </p> <p>We graded each potential source of bias as high, low, or unclear and provided a quote from the study report together with a justification for our judgement in the 'Risk of bias' table. We summarised the 'Risk of bias' judgements across different studies for each of the domains listed. Where information on risk of bias related to unpublished data or correspondence with a trialist, we noted this in the 'Risk of bias' table. The domains were all weighted equally, and disagreements were resolved by consensus. </p> </section> <section id="CD004370-sec-0032"> <h4 class="title">Measures of treatment effect</h4> <p>Dichotomous data (e.g. event‐free survival, overall survival, occurrence of side effects, complete recovery) were expressed as risk ratio (RR) with 95% confidence intervals (CIs). We measured event‐free survival as risk of an event (death, cardiac transplant, placement of a left ventricular assist device) occurring; overall survival as the risk of death; side effects as the risk of side effects occurring; and recovery as failure to attain complete recovery. We derived the number needed to treat for an additional harmful outcome (NNTH) to help clarify the extent of adverse effects. We converted continuous data (e.g. change in LVEF, change in LVEDD, and peak oxygen consumption) to mean differences (MDs) with 95% CIs. </p> </section> <section id="CD004370-sec-0033"> <h4 class="title">Unit of analysis issues</h4> <p>We planned to analyse cluster‐randomised trials in accordance with the guidance in Section 16.3.2 of the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> (<a href="./references#CD004370-bbs2-0041" title="HigginsJP , ThomasJ , ChandlerJ , CumpstonM , LiT , PageMJ , Welch VA (editors). Cochrane Handbook for Systematic Reviews of Interventions version 6.0 (updated July 2019). Available from www.training.cochrane.org/handbook: Cochrane, 2019.">Higgins 2019</a>), but no such studies have as yet been identified. We planned that for trials with multiple arms, we would divide the control group N by the number of arms to avoid double‐counting in meta‐analyses; however, this was not applicable to the studies included in the review. </p> </section> <section id="CD004370-sec-0034"> <h4 class="title">Dealing with missing data</h4> <p>We contacted investigators or study sponsors in order to verify key study characteristics and to obtain missing numerical outcome data where possible (e.g. when a study was identified as abstract only). </p> </section> <section id="CD004370-sec-0035"> <h4 class="title">Assessment of heterogeneity</h4> <p>We inspected forest plots visually to consider the direction and magnitude of effects and the degree of overlap between confidence intervals. We used the I<sup>2</sup> statistic to measure heterogeneity amongst the trials in each analysis, but acknowledge that there is substantial uncertainty in the value of I<sup>2</sup> when there is only a small number of studies. We also considered the P value from the Chi<sup>2</sup> test. </p> <p>We planned that if we identified substantial heterogeneity (50% to 90%), we would report it and explore possible causes by prespecified subgroup analysis. Where heterogeneity was considerable (75% to 100%), we would not pool studies statistically but present them in forest plots and suppress the summary effect estimate. </p> </section> <section id="CD004370-sec-0036"> <h4 class="title">Assessment of reporting biases</h4> <p>Due to the small number of included studies, we were only able to conduct one meta‐analysis. As the meta‐analysis only included two studies, it was not possible to examine publication bias using a funnel plot. </p> </section> <section id="CD004370-sec-0037"> <h4 class="title">Data synthesis</h4> <p>Meta‐analysis was only possible for two outcomes (overall survival and change in LVEF) with data provided from two adult trials. Other meta‐analyses were not possible because only three trials were included in the review, which enrolled completely different populations and measured outcomes in different ways. </p> <p>For peak oxygen consumption, we assumed a correlation of 0.5 and used the methods of Follmann to calculate the SDs of the change from baseline estimates (<a href="./references#CD004370-bbs2-0035" title="FollmannD , ElliottP , SuhI , CutlerJ . Variance imputation for overviews of clinical trials with continuous response. Journal of Clinical Epidemiology1992;45(7):769-73.">Follmann 1992</a>). <a href="./references#CD004370-bbs2-0003" title="McNamaraDM , HolubkovR , StarlingRC , DecGW , LohE , Torre-AmioneG , et al. Controlled trial of intravenous immune globulin in recent-onset dilated cardiomyopathy. Circulation2001;103(18):2254-9. McNamaraDM , StarlingRC , DecGW , LohE , Torre-AmioneG , GassA , et al. Intervention in myocarditis and acute cardiomyopathy with immune globulin: results from the randomized placebo controlled IMAC trial. Circulation1999;100(18):104. ">McNamara 2001</a> reported this variable and calculated the value only on the portion of the sample for which data were available (48/62 participants). The study authors did not provide the breakdown of sample size in each group, only a total sample size. They calculated an estimate of sample size in each group by pro‐rating the original group sample sizes to the new total sample size. </p> </section> <section id="CD004370-sec-0038"> <h4 class="title">Subgroup analysis and investigation of heterogeneity</h4> <p>We prespecified a subgroup analysis of cardiac biopsies that fulfilled the Dallas, <a href="./references#CD004370-bbs2-0033" title="AretzHT . Myocarditis: the Dallas criteria. Human Pathology1987;18:619-24.">Aretz 1987</a>, or World Heart Federation, <a href="./references#CD004370-bbs2-0046" title="MaischB , BültmannB , FactorS , GroeneHJ , HufnagelG , KawarmuraK , et al. World Heart Federation consensus conferences's definition of inflammatory cardiomyopathy (myocarditis): report from two expert committees on histology and viral cardiomyopathy. Heartbeat1999;4:3-4.">Maisch 1999</a>; <a href="./references#CD004370-bbs2-0047" title="MaischB , PortigI , RisticA , HufnagelG , PankuweitS . Definition of inflammatory cardiomyopathy (myocarditis): on the way to consensus. Herz2000;25:200-9.">Maisch 2000</a>, criteria for acute myocarditis to investigate possible heterogeneity; however, due to an insufficient number of included studies we could not undertake this analysis. </p> </section> <section id="CD004370-sec-0039"> <h4 class="title">Sensitivity analysis</h4> <p>We did not undertake a sensitivity analysis due to the limited number of included studies. </p> </section> <section id="CD004370-sec-0040"> <h4 class="title">Summary of findings and assessment of the certainty of the evidence</h4> <p>We developed 'Summary of findings' tables (<a href="./full#CD004370-tbl-0001">summary of findings Table 1</a>; <a href="./full#CD004370-tbl-0002">summary of findings Table 2</a>) for both the adult and paediatric populations using the primary outcome of survival (both event‐free survival and overall survival). In order to present a balanced picture of benefits and harms, side effects were also included as an outcome in the adult population; side effects were not reported in children. For each outcome, two review authors (JR, MS) independently applied the GRADE methods to determine the certainty of the evidence as outlined in the GRADE Handbook (<a href="./references#CD004370-bbs2-0054" title="SchünemannH , BrożekJ , GuyattG , OxmanA , editor(s). Handbook for grading the quality of evidence and the strength of recommendations using the GRADE approach (updated October 2013). GRADE Working Group, 2013. Available from gdt.guidelinedevelopment.org/app/handbook/handbook.html.">Schunemann 2013</a>). We decided whether or not to downgrade the certainty of the evidence one or two levels for each of the five domains (risk of bias, inconsistency, indirectness, imprecision, and publication bias). Any disagreements were resolved through discussion, and all decisions were justified in the footnotes for transparency. </p> </section> </section> </section> </section> <section class="results"> <div class="section-header section-collapse-header" id="CD004370-sec-0041" lang="en"> <h2 class="title section-collapse-title"> Results <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="results" lang="en"> <div class="section-header" id="CD004370-sec-0041"></div> <section id="CD004370-sec-0042"> <h3 class="title">Description of studies</h3> <section id="CD004370-sec-0043"> <h4 class="title">Results of the search</h4> <p>In the updated search in July 2019, we identified 467 unique references of which 15 references were judged as potentially relevant. We excluded 12 studies that were not randomised or did not evaluate IVIG. One study was identified as ongoing. Two new studies met the inclusion criteria, so in addition to the study included in the previous version of the review, three studies are now included in the review (<a href="#CD004370-fig-0001">Figure 1</a>) (<a href="./references#CD004370-bbs2-0001" title="El-SaiediSA . Randomized controlled trial on the use of intravenous immune globulin in acute pediatric myocarditis. Journal of Clinical Research &amp; Bioethics2013;5(1):1-5. ">El‐Saiedi 2013</a>; <a href="./references#CD004370-bbs2-0002" title="KishimotoC , ShiojiK , HashimotoT , NonogiH , LeeJD , KatoS , et al. Therapy with immunoglobulin in patients with acute myocarditis and cardiomyopathy: analysis of leukocyte balance. Heart Vessels2014;29:336-42. ">Kishimoto 2014</a>; <a href="./references#CD004370-bbs2-0003" title="McNamaraDM , HolubkovR , StarlingRC , DecGW , LohE , Torre-AmioneG , et al. Controlled trial of intravenous immune globulin in recent-onset dilated cardiomyopathy. Circulation2001;103(18):2254-9. McNamaraDM , StarlingRC , DecGW , LohE , Torre-AmioneG , GassA , et al. Intervention in myocarditis and acute cardiomyopathy with immune globulin: results from the randomized placebo controlled IMAC trial. Circulation1999;100(18):104. ">McNamara 2001</a>). Agreement between the two review authors was 100% with respect to study relevance. </p> <div class="figure" id="CD004370-fig-0001"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 1</div> </div> <hr class="top"/><img alt="Study flow diagram." data-id="CD004370-fig-0001" src="/cdsr/doi/10.1002/14651858.CD004370.pub4/media/CDSR/CD004370/image_n/nCD004370-FIG-01.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Study flow diagram.</p> </div> </div> </div> </section> <section id="CD004370-sec-0044"> <h4 class="title">Included studies</h4> <p>See <a href="./references#CD004370-sec-0105" title="">Characteristics of included studies</a> for further details. </p> <p>Two randomised trials of IVIG in adults and one in children have been reported to date (<a href="./references#CD004370-bbs2-0001" title="El-SaiediSA . Randomized controlled trial on the use of intravenous immune globulin in acute pediatric myocarditis. Journal of Clinical Research &amp; Bioethics2013;5(1):1-5. ">El‐Saiedi 2013</a>; <a href="./references#CD004370-bbs2-0002" title="KishimotoC , ShiojiK , HashimotoT , NonogiH , LeeJD , KatoS , et al. Therapy with immunoglobulin in patients with acute myocarditis and cardiomyopathy: analysis of leukocyte balance. Heart Vessels2014;29:336-42. ">Kishimoto 2014</a>; <a href="./references#CD004370-bbs2-0003" title="McNamaraDM , HolubkovR , StarlingRC , DecGW , LohE , Torre-AmioneG , et al. Controlled trial of intravenous immune globulin in recent-onset dilated cardiomyopathy. Circulation2001;103(18):2254-9. McNamaraDM , StarlingRC , DecGW , LohE , Torre-AmioneG , GassA , et al. Intervention in myocarditis and acute cardiomyopathy with immune globulin: results from the randomized placebo controlled IMAC trial. Circulation1999;100(18):104. ">McNamara 2001</a>). </p> <p><a href="./references#CD004370-bbs2-0003" title="McNamaraDM , HolubkovR , StarlingRC , DecGW , LohE , Torre-AmioneG , et al. Controlled trial of intravenous immune globulin in recent-onset dilated cardiomyopathy. Circulation2001;103(18):2254-9. McNamaraDM , StarlingRC , DecGW , LohE , Torre-AmioneG , GassA , et al. Intervention in myocarditis and acute cardiomyopathy with immune globulin: results from the randomized placebo controlled IMAC trial. Circulation1999;100(18):104. ">McNamara 2001</a> was conducted in the USA and published in English. This placebo‐controlled trial evaluated the efficacy of IVIG amongst 62 adults (mean age 43.0 years, SD 12.3 years) with new‐onset (within six months) dilated cardiomyopathy, normal coronary angiography, and LVEF ≤ 0.40. All participants had endomyocardial biopsies, but only 10 had cellular inflammation (four fulfilled the Dallas criteria for myocarditis, three had borderline myocarditis, and three had non‐specific inflammation). Participants were randomly assigned to receive 2 g/kg IVIG or an equivalent volume of 0.1% albumin in a blinded fashion. </p> <p><a href="./references#CD004370-bbs2-0002" title="KishimotoC , ShiojiK , HashimotoT , NonogiH , LeeJD , KatoS , et al. Therapy with immunoglobulin in patients with acute myocarditis and cardiomyopathy: analysis of leukocyte balance. Heart Vessels2014;29:336-42. ">Kishimoto 2014</a> was conducted in Japan and published in English. This multicentre randomised trial evaluated the prognosis of 41 adults (range 19 to 80 years of age) with a clinical diagnosis compatible with acute myocarditis. It is not clear how many participants had cardiac biopsies. Participants presented with an LVEF ≤ 0.40, recent onset of symptoms (less than six months), and no evidence of valvular or ischaemic heart disease. Pretreatment catheterisation with coronary angiography and endomyocardial biopsy was completed in 20 participants. Participants were randomised to two groups: IVIG (1 to 2 g/kg over two days) or no treatment. </p> <p><a href="./references#CD004370-bbs2-0001" title="El-SaiediSA . Randomized controlled trial on the use of intravenous immune globulin in acute pediatric myocarditis. Journal of Clinical Research &amp; Bioethics2013;5(1):1-5. ">El‐Saiedi 2013</a> was conducted in Egypt and published in English. This randomised placebo‐controlled study evaluated the addition of IVIG to conventional therapy in 86 children (ranging from 4 months to 6 years of age) with acute‐onset dilated cardiomyopathy and an LVSF less than 20%. Children were randomly allocated to receive 1 g/kg IVIG or a placebo of 5% glucose intravenous fluids 10 mL/kg daily for two consecutive days. There was no evidence of differences in clinical parameters at baseline between the two groups with the exception of cardiac enzymes (CPK), which were higher in the placebo group (IVIG: 155.6 ± 33.9 versus placebo: 243.2 ± 34.2; P = 0.002). </p> <p>Funding for the McNamara study was provided by a pharmaceutical company in the form of an educational grant (<a href="./references#CD004370-bbs2-0003" title="McNamaraDM , HolubkovR , StarlingRC , DecGW , LohE , Torre-AmioneG , et al. Controlled trial of intravenous immune globulin in recent-onset dilated cardiomyopathy. Circulation2001;103(18):2254-9. McNamaraDM , StarlingRC , DecGW , LohE , Torre-AmioneG , GassA , et al. Intervention in myocarditis and acute cardiomyopathy with immune globulin: results from the randomized placebo controlled IMAC trial. Circulation1999;100(18):104. ">McNamara 2001</a>). Funding for the Kishimoto study was provided by grants from the Japanese Ministry of Education, Science and Culture, the Shimizu Immunology Foundation, the All Coffee Association, The Universe Foundation, and the Cardiovascular Research Foundation (<a href="./references#CD004370-bbs2-0002" title="KishimotoC , ShiojiK , HashimotoT , NonogiH , LeeJD , KatoS , et al. Therapy with immunoglobulin in patients with acute myocarditis and cardiomyopathy: analysis of leukocyte balance. Heart Vessels2014;29:336-42. ">Kishimoto 2014</a>). The funding source for the El‐Saiedi study was not specified (<a href="./references#CD004370-bbs2-0001" title="El-SaiediSA . Randomized controlled trial on the use of intravenous immune globulin in acute pediatric myocarditis. Journal of Clinical Research &amp; Bioethics2013;5(1):1-5. ">El‐Saiedi 2013</a>). </p> <section id="CD004370-sec-0045"> <h5 class="title">Ongoing studies</h5> <p>See <a href="./references#CD004370-sec-0107" title="">Characteristics of ongoing studies</a> for further details. </p> <p>We identified a total of three ongoing trials. Results have not yet been reported from the European Study of Epidemiology and Treatment of Cardiac Inflammatory Diseases (ESETCID) (<a href="./references#CD004370-bbs2-0031" title="HufnagelG , PankuweitS , RichterA , SchonianU , MaischB , for the ESETCID Investigators. The European Study of Epidemiology and Treatment of Cardiac Inflammatory Diseases (ESETCID). First epidemiological results. Herz2000;25(3):279-85. ">Hufnagel 2000</a>). This trial involves different therapies depending on the expected pathogenesis of myocarditis, and at least one of the study arms involves immunoglobulin therapy. The Immunoglobulin Therapy for Patients With Idiopathic Cardiomyopathy and Endomyocardial Parvovirus B19 Persistence Trial was completed in June 2018; however, no results have been reported (<a href="./references#CD004370-bbs2-0030" title="HeymansS . Immunoglobulin therapy for patients with idiopathic cardiomyopathy and endomyocardial parvovirus B19 persistence - a prospective, double-blind, randomized, placebo-controlled clinical trial. clinicaltrials.gov/ct2/show/NCT00892112 (first received 4 May 2009). ">Heymans 2018</a>). A new trial in India of intravenous IVIG in young patients with recent‐onset dilated cardiomyopathy has been registered, but results are not yet available (<a href="./references#CD004370-bbs2-0032" title="MarotraoPS , VermaS . Randomized trial on use of intravenous immunoglobulin in young patients with recent onset dilated cardiomyopathy. www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=20913 (registered 18 January 2018). ">Marotrao 2018</a>).  </p> </section> </section> <section id="CD004370-sec-0046"> <h4 class="title">Excluded studies</h4> <p>See <a href="./references#CD004370-sec-0106" title="">Characteristics of excluded studies</a> for further details. </p> <p>We excluded a total of 26 studies for the following reasons: not an RCT (16 studies), different population (6 studies), different intervention (3 studies), and one study, an abstract, did not report any results. </p> </section> </section> <section id="CD004370-sec-0047"> <h3 class="title">Risk of bias in included studies</h3> <p>Overall risk of bias was unclear in the two adult studies, <a href="./references#CD004370-bbs2-0002" title="KishimotoC , ShiojiK , HashimotoT , NonogiH , LeeJD , KatoS , et al. Therapy with immunoglobulin in patients with acute myocarditis and cardiomyopathy: analysis of leukocyte balance. Heart Vessels2014;29:336-42. ">Kishimoto 2014</a>; <a href="./references#CD004370-bbs2-0003" title="McNamaraDM , HolubkovR , StarlingRC , DecGW , LohE , Torre-AmioneG , et al. Controlled trial of intravenous immune globulin in recent-onset dilated cardiomyopathy. Circulation2001;103(18):2254-9. McNamaraDM , StarlingRC , DecGW , LohE , Torre-AmioneG , GassA , et al. Intervention in myocarditis and acute cardiomyopathy with immune globulin: results from the randomized placebo controlled IMAC trial. Circulation1999;100(18):104. ">McNamara 2001</a>, and low in the paediatric study (<a href="#CD004370-fig-0002">Figure 2</a>; <a href="#CD004370-fig-0003">Figure 3</a>) (<a href="./references#CD004370-bbs2-0001" title="El-SaiediSA . Randomized controlled trial on the use of intravenous immune globulin in acute pediatric myocarditis. Journal of Clinical Research &amp; Bioethics2013;5(1):1-5. ">El‐Saiedi 2013</a>). </p> <div class="figure" id="CD004370-fig-0002"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 2</div> </div> <hr class="top"/><img alt="Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies." data-id="CD004370-fig-0002" src="/cdsr/doi/10.1002/14651858.CD004370.pub4/media/CDSR/CD004370/image_n/nCD004370-FIG-02.svg"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies. </p> </div> </div> </div> <div class="figure" id="CD004370-fig-0003"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 3</div> </div> <hr class="top"/><img alt="Risk of bias summary: review authors' judgements about each risk of bias item for each included study." data-id="CD004370-fig-0003" src="/cdsr/doi/10.1002/14651858.CD004370.pub4/media/CDSR/CD004370/image_n/nCD004370-FIG-03.svg"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Risk of bias summary: review authors' judgements about each risk of bias item for each included study. </p> </div> </div> </div> <section id="CD004370-sec-0048"> <h4 class="title">Allocation</h4> <p>Selection bias was unclear across the included studies. Methods of randomisation and allocation concealment were not reported in <a href="./references#CD004370-bbs2-0002" title="KishimotoC , ShiojiK , HashimotoT , NonogiH , LeeJD , KatoS , et al. Therapy with immunoglobulin in patients with acute myocarditis and cardiomyopathy: analysis of leukocyte balance. Heart Vessels2014;29:336-42. ">Kishimoto 2014</a>, and there was a lack of detailed explanation regarding the use of block randomisation and double‐blinding in relation to allocation concealment in <a href="./references#CD004370-bbs2-0003" title="McNamaraDM , HolubkovR , StarlingRC , DecGW , LohE , Torre-AmioneG , et al. Controlled trial of intravenous immune globulin in recent-onset dilated cardiomyopathy. Circulation2001;103(18):2254-9. McNamaraDM , StarlingRC , DecGW , LohE , Torre-AmioneG , GassA , et al. Intervention in myocarditis and acute cardiomyopathy with immune globulin: results from the randomized placebo controlled IMAC trial. Circulation1999;100(18):104. ">McNamara 2001</a>. <a href="./references#CD004370-bbs2-0001" title="El-SaiediSA . Randomized controlled trial on the use of intravenous immune globulin in acute pediatric myocarditis. Journal of Clinical Research &amp; Bioethics2013;5(1):1-5. ">El‐Saiedi 2013</a> used a random table block stratified by a clinical centre where allocation was managed by a third party and used a placebo, and was therefore judged as having a low risk of selection bias. </p> </section> <section id="CD004370-sec-0049"> <h4 class="title">Blinding</h4> <p>Performance bias and detection bias were unclear across the included studies. No blinding was reported in <a href="./references#CD004370-bbs2-0002" title="KishimotoC , ShiojiK , HashimotoT , NonogiH , LeeJD , KatoS , et al. Therapy with immunoglobulin in patients with acute myocarditis and cardiomyopathy: analysis of leukocyte balance. Heart Vessels2014;29:336-42. ">Kishimoto 2014</a>, resulting in insufficient information to determine risk of bias. In <a href="./references#CD004370-bbs2-0003" title="McNamaraDM , HolubkovR , StarlingRC , DecGW , LohE , Torre-AmioneG , et al. Controlled trial of intravenous immune globulin in recent-onset dilated cardiomyopathy. Circulation2001;103(18):2254-9. McNamaraDM , StarlingRC , DecGW , LohE , Torre-AmioneG , GassA , et al. Intervention in myocarditis and acute cardiomyopathy with immune globulin: results from the randomized placebo controlled IMAC trial. Circulation1999;100(18):104. ">McNamara 2001</a>, double‐blinding is mentioned but not explained, therefore this study was judged as at unclear risk of bias. <a href="./references#CD004370-bbs2-0001" title="El-SaiediSA . Randomized controlled trial on the use of intravenous immune globulin in acute pediatric myocarditis. Journal of Clinical Research &amp; Bioethics2013;5(1):1-5. ">El‐Saiedi 2013</a> used a placebo, and both groups received the same follow‐up, resulting in a determination of low risk of bias for this domain. </p> </section> <section id="CD004370-sec-0050"> <h4 class="title">Incomplete outcome data</h4> <p>Attrition bias was unclear across the included studies. <a href="./references#CD004370-bbs2-0001" title="El-SaiediSA . Randomized controlled trial on the use of intravenous immune globulin in acute pediatric myocarditis. Journal of Clinical Research &amp; Bioethics2013;5(1):1-5. ">El‐Saiedi 2013</a> did not report the number of participants lost to follow‐up, and whilst the outcome data for the primary outcome were complete in <a href="./references#CD004370-bbs2-0003" title="McNamaraDM , HolubkovR , StarlingRC , DecGW , LohE , Torre-AmioneG , et al. Controlled trial of intravenous immune globulin in recent-onset dilated cardiomyopathy. Circulation2001;103(18):2254-9. McNamaraDM , StarlingRC , DecGW , LohE , Torre-AmioneG , GassA , et al. Intervention in myocarditis and acute cardiomyopathy with immune globulin: results from the randomized placebo controlled IMAC trial. Circulation1999;100(18):104. ">McNamara 2001</a>, measurements of functional capacity were incomplete with no explanation provided. We assessed both studies as at unclear risk of bias for this domain. <a href="./references#CD004370-bbs2-0002" title="KishimotoC , ShiojiK , HashimotoT , NonogiH , LeeJD , KatoS , et al. Therapy with immunoglobulin in patients with acute myocarditis and cardiomyopathy: analysis of leukocyte balance. Heart Vessels2014;29:336-42. ">Kishimoto 2014</a> reported that "all patients were followed up for a median of 3.5 months after therapy", and Table 1 appears to be complete, resulting in a determination of low risk of attrition bias. </p> </section> <section id="CD004370-sec-0051"> <h4 class="title">Selective reporting</h4> <p>Reporting bias was unclear across the included studies, as insufficient information was reported in <a href="./references#CD004370-bbs2-0001" title="El-SaiediSA . Randomized controlled trial on the use of intravenous immune globulin in acute pediatric myocarditis. Journal of Clinical Research &amp; Bioethics2013;5(1):1-5. ">El‐Saiedi 2013</a> and <a href="./references#CD004370-bbs2-0002" title="KishimotoC , ShiojiK , HashimotoT , NonogiH , LeeJD , KatoS , et al. Therapy with immunoglobulin in patients with acute myocarditis and cardiomyopathy: analysis of leukocyte balance. Heart Vessels2014;29:336-42. ">Kishimoto 2014</a>. <a href="./references#CD004370-bbs2-0003" title="McNamaraDM , HolubkovR , StarlingRC , DecGW , LohE , Torre-AmioneG , et al. Controlled trial of intravenous immune globulin in recent-onset dilated cardiomyopathy. Circulation2001;103(18):2254-9. McNamaraDM , StarlingRC , DecGW , LohE , Torre-AmioneG , GassA , et al. Intervention in myocarditis and acute cardiomyopathy with immune globulin: results from the randomized placebo controlled IMAC trial. Circulation1999;100(18):104. ">McNamara 2001</a> had a low risk of reporting bias as all prespecified outcomes were reported. </p> </section> <section id="CD004370-sec-0052"> <h4 class="title">Other potential sources of bias</h4> <p>No other potential sources of bias were noted.</p> </section> </section> <section id="CD004370-sec-0053"> <h3 class="title" id="CD004370-sec-0053">Effects of interventions</h3> <p>See: <a href="./full#CD004370-tbl-0001"><b>Summary of findings 1</b> Intravenous immunoglobulin compared with placebo or no treatment for adults with acute myocarditis</a>; <a href="./full#CD004370-tbl-0002"><b>Summary of findings 2</b> Intravenous immunoglobulin compared with placebo or no treatment for children with acute myocarditis</a> </p> <section id="CD004370-sec-0054"> <h4 class="title">Survival</h4> <p>The evidence regarding the effect of IVIG on event‐free survival and overall survival in adults (event‐free survival: risk ratio (RR) 1.76, 95% confidence interval (CI) 0.48 to 6.40; very low‐certainty evidence, median follow‐up time of 23 months (range 14 to 41 months); overall survival: pooled RR 0.91, 95% CI 0.23 to 3.62; very low‐certainty evidence) is uncertain (<a href="./references#CD004370-fig-0004" title="">Analysis 1.1</a>; <a href="./references#CD004370-fig-0005" title="">Analysis 1.2</a>) (<a href="./references#CD004370-bbs2-0002" title="KishimotoC , ShiojiK , HashimotoT , NonogiH , LeeJD , KatoS , et al. Therapy with immunoglobulin in patients with acute myocarditis and cardiomyopathy: analysis of leukocyte balance. Heart Vessels2014;29:336-42. ">Kishimoto 2014</a>; <a href="./references#CD004370-bbs2-0003" title="McNamaraDM , HolubkovR , StarlingRC , DecGW , LohE , Torre-AmioneG , et al. Controlled trial of intravenous immune globulin in recent-onset dilated cardiomyopathy. Circulation2001;103(18):2254-9. McNamaraDM , StarlingRC , DecGW , LohE , Torre-AmioneG , GassA , et al. Intervention in myocarditis and acute cardiomyopathy with immune globulin: results from the randomized placebo controlled IMAC trial. Circulation1999;100(18):104. ">McNamara 2001</a>). The Kishimoto study did report longer survival time (defined as time to event) in the IVIG group during an average follow‐up time of 60 days; however, no raw data were reported (P &lt; 0.01) (<a href="./references#CD004370-bbs2-0002" title="KishimotoC , ShiojiK , HashimotoT , NonogiH , LeeJD , KatoS , et al. Therapy with immunoglobulin in patients with acute myocarditis and cardiomyopathy: analysis of leukocyte balance. Heart Vessels2014;29:336-42. ">Kishimoto 2014</a>). </p> <p>In the paediatric study, evidence for overall survival was uncertain (RR of death 0.48, 95% CI 0.20 to 1.15; very low‐certainty evidence; <a href="./references#CD004370-fig-0010" title="">Analysis 2.1</a>) with a follow‐up time of six months (<a href="./references#CD004370-bbs2-0001" title="El-SaiediSA . Randomized controlled trial on the use of intravenous immune globulin in acute pediatric myocarditis. Journal of Clinical Research &amp; Bioethics2013;5(1):1-5. ">El‐Saiedi 2013</a>). Event‐free survival was not reported. </p> </section> <section id="CD004370-sec-0055"> <h4 class="title">Improvement in LVEF</h4> <p>Evidence was uncertain for improvement in LVEF between the IVIG group and the control group for the two adult trials (mean difference (MD) −0.01, 95% CI −0.06 to 0.05) after 12 months, <a href="./references#CD004370-bbs2-0003" title="McNamaraDM , HolubkovR , StarlingRC , DecGW , LohE , Torre-AmioneG , et al. Controlled trial of intravenous immune globulin in recent-onset dilated cardiomyopathy. Circulation2001;103(18):2254-9. McNamaraDM , StarlingRC , DecGW , LohE , Torre-AmioneG , GassA , et al. Intervention in myocarditis and acute cardiomyopathy with immune globulin: results from the randomized placebo controlled IMAC trial. Circulation1999;100(18):104. ">McNamara 2001</a>, and an unknown time frame, <a href="./references#CD004370-bbs2-0002" title="KishimotoC , ShiojiK , HashimotoT , NonogiH , LeeJD , KatoS , et al. Therapy with immunoglobulin in patients with acute myocarditis and cardiomyopathy: analysis of leukocyte balance. Heart Vessels2014;29:336-42. ">Kishimoto 2014</a> (<a href="./references#CD004370-fig-0006" title="">Analysis 1.3</a>). The overall certainty of the evidence was very low.  </p> </section> <section id="CD004370-sec-0056"> <h4 class="title">Improvement in LVEDD</h4> <p>In the paediatric study, improvement in LVEDD was seen in both the IVIG and control groups after six months, with uncertain evidence of a difference between groups (MD −4.00, 95% CI −9.52 to 1.52; very low‐certainty evidence; <a href="./references#CD004370-fig-0011" title="">Analysis 2.2</a>) (<a href="./references#CD004370-bbs2-0001" title="El-SaiediSA . Randomized controlled trial on the use of intravenous immune globulin in acute pediatric myocarditis. Journal of Clinical Research &amp; Bioethics2013;5(1):1-5. ">El‐Saiedi 2013</a>). </p> </section> <section id="CD004370-sec-0057"> <h4 class="title">Improvement in LVSF</h4> <p>In the paediatric study, both the IVIG and control groups showed improvement in LVSF after six months, with uncertain evidence of a difference between groups (no numerical data; very low‐certainty evidence) (<a href="./references#CD004370-bbs2-0001" title="El-SaiediSA . Randomized controlled trial on the use of intravenous immune globulin in acute pediatric myocarditis. Journal of Clinical Research &amp; Bioethics2013;5(1):1-5. ">El‐Saiedi 2013</a>). </p> </section> <section id="CD004370-sec-0058"> <h4 class="title">Improvement in functional capacity</h4> <p>The results of functional capacity as assessed by peak oxygen consumption was uncertain at 12 months (MD −0.80, 95% CI −4.57 to 2.97; very low‐certainty evidence) (<a href="./references#CD004370-fig-0007" title="">Analysis 1.4</a>) (<a href="./references#CD004370-bbs2-0003" title="McNamaraDM , HolubkovR , StarlingRC , DecGW , LohE , Torre-AmioneG , et al. Controlled trial of intravenous immune globulin in recent-onset dilated cardiomyopathy. Circulation2001;103(18):2254-9. McNamaraDM , StarlingRC , DecGW , LohE , Torre-AmioneG , GassA , et al. Intervention in myocarditis and acute cardiomyopathy with immune globulin: results from the randomized placebo controlled IMAC trial. Circulation1999;100(18):104. ">McNamara 2001</a>). No other measures of functional capacity were reported. </p> </section> <section id="CD004370-sec-0059"> <h4 class="title">Side effects</h4> <p>In adults, the evidence for adverse events potentially related to IVIG was uncertain. Adverse events only occurred in the treated group, and all were described as mild infusion reactions (RR 20.29, 95% CI 1.25 to 329.93; NNTH = 3) (<a href="./references#CD004370-fig-0008" title="">Analysis 1.5</a>) (<a href="./references#CD004370-bbs2-0003" title="McNamaraDM , HolubkovR , StarlingRC , DecGW , LohE , Torre-AmioneG , et al. Controlled trial of intravenous immune globulin in recent-onset dilated cardiomyopathy. Circulation2001;103(18):2254-9. McNamaraDM , StarlingRC , DecGW , LohE , Torre-AmioneG , GassA , et al. Intervention in myocarditis and acute cardiomyopathy with immune globulin: results from the randomized placebo controlled IMAC trial. Circulation1999;100(18):104. ">McNamara 2001</a>). In children, a few participants noted flu‐like symptoms, but no major adverse events were reported including hypotension or anaphylaxis (<a href="./references#CD004370-bbs2-0001" title="El-SaiediSA . Randomized controlled trial on the use of intravenous immune globulin in acute pediatric myocarditis. Journal of Clinical Research &amp; Bioethics2013;5(1):1-5. ">El‐Saiedi 2013</a>). The overall certainty of the evidence was very low. </p> </section> <section id="CD004370-sec-0060"> <h4 class="title">Failure to attain complete recovery</h4> <p>The evidence regarding the effect of IVIG on whether participants fully recovered was uncertain (RR 0.46, 95% CI 0.19 to 1.14; very low‐certainty evidence) (<a href="./references#CD004370-fig-0009" title="">Analysis 1.6</a>) (<a href="./references#CD004370-bbs2-0002" title="KishimotoC , ShiojiK , HashimotoT , NonogiH , LeeJD , KatoS , et al. Therapy with immunoglobulin in patients with acute myocarditis and cardiomyopathy: analysis of leukocyte balance. Heart Vessels2014;29:336-42. ">Kishimoto 2014</a>). </p> </section> <section id="CD004370-sec-0061"> <h4 class="title">Hospitalisation status</h4> <p>No evidence regarding hospitalisation status was reported in any of the included studies.</p> </section> </section> </section> </section> <section class="discussion"> <div class="section-header section-collapse-header" id="CD004370-sec-0062" lang="en"> <h2 class="title section-collapse-title"> Discussion <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="discussion" lang="en"> <div class="section-header" id="CD004370-sec-0062"></div> <section id="CD004370-sec-0063"> <h3 class="title" id="CD004370-sec-0063">Summary of main results</h3> <p>Two adult studies with an unclear risk of bias and one paediatric study with a low risk of bias showed no benefit of IVIG for the primary outcome (transplant‐free or overall survival) (<a href="./full#CD004370-tbl-0001">summary of findings Table 1</a>, <a href="./full#CD004370-tbl-0002">summary of findings Table 2</a>). However, one of the adult studies reported longer survival time in the first 60 days in the IVIG group (<a href="./references#CD004370-bbs2-0002" title="KishimotoC , ShiojiK , HashimotoT , NonogiH , LeeJD , KatoS , et al. Therapy with immunoglobulin in patients with acute myocarditis and cardiomyopathy: analysis of leukocyte balance. Heart Vessels2014;29:336-42. ">Kishimoto 2014</a>). With regard to secondary outcomes, one adult study showed no improvement in LVEF (<a href="./references#CD004370-bbs2-0003" title="McNamaraDM , HolubkovR , StarlingRC , DecGW , LohE , Torre-AmioneG , et al. Controlled trial of intravenous immune globulin in recent-onset dilated cardiomyopathy. Circulation2001;103(18):2254-9. McNamaraDM , StarlingRC , DecGW , LohE , Torre-AmioneG , GassA , et al. Intervention in myocarditis and acute cardiomyopathy with immune globulin: results from the randomized placebo controlled IMAC trial. Circulation1999;100(18):104. ">McNamara 2001</a>); the paediatric study showed no improvement in LVEDD or LVSF (<a href="./references#CD004370-bbs2-0001" title="El-SaiediSA . Randomized controlled trial on the use of intravenous immune globulin in acute pediatric myocarditis. Journal of Clinical Research &amp; Bioethics2013;5(1):1-5. ">El‐Saiedi 2013</a>); and one adult study showed no improvement in functional capacity when last measured (<a href="./references#CD004370-bbs2-0003" title="McNamaraDM , HolubkovR , StarlingRC , DecGW , LohE , Torre-AmioneG , et al. Controlled trial of intravenous immune globulin in recent-onset dilated cardiomyopathy. Circulation2001;103(18):2254-9. McNamaraDM , StarlingRC , DecGW , LohE , Torre-AmioneG , GassA , et al. Intervention in myocarditis and acute cardiomyopathy with immune globulin: results from the randomized placebo controlled IMAC trial. Circulation1999;100(18):104. ">McNamara 2001</a>). </p> </section> <section id="CD004370-sec-0064"> <h3 class="title" id="CD004370-sec-0064">Overall completeness and applicability of evidence</h3> <p>There is residual doubt, particularly in the paediatric study, as to whether all enrolled participants truly have acute myocarditis (<a href="./references#CD004370-bbs2-0001" title="El-SaiediSA . Randomized controlled trial on the use of intravenous immune globulin in acute pediatric myocarditis. Journal of Clinical Research &amp; Bioethics2013;5(1):1-5. ">El‐Saiedi 2013</a>). Whilst the meta‐analysis of overall survival showed low heterogeneity, not all of the participants may have had confirmed myocarditis (<a href="./references#CD004370-bbs2-0003" title="McNamaraDM , HolubkovR , StarlingRC , DecGW , LohE , Torre-AmioneG , et al. Controlled trial of intravenous immune globulin in recent-onset dilated cardiomyopathy. Circulation2001;103(18):2254-9. McNamaraDM , StarlingRC , DecGW , LohE , Torre-AmioneG , GassA , et al. Intervention in myocarditis and acute cardiomyopathy with immune globulin: results from the randomized placebo controlled IMAC trial. Circulation1999;100(18):104. ">McNamara 2001</a>). This, combined with the small sample size and the variation in the eligibility criteria and reported outcomes, means that the results of the three included studies may not be applicable to all adults and children with suspected acute myocarditis. </p> <p>As acute myocarditis is a relatively non‐specific entity, it is possible that a subset of patients may respond to IVIG. This group might include patients whose disease was precipitated by a specific virus, or patients treated with IVIG early in the course of their illness, when they have ongoing viral replication in the myocardium. Paediatric patients may be more likely to respond, as the chance that an acute cardiomyopathy is due to viral myocarditis is probably greater in children than in adults. </p> </section> <section id="CD004370-sec-0065"> <h3 class="title" id="CD004370-sec-0065">Quality of the evidence</h3> <p>The overall certainty of the evidence was very low. The quality of the evidence was downgraded most often due to an unclear risk of bias, as randomisation methods were unclear or not reported, and for imprecision due to the confidence interval failing to exclude either a benefit or a harm and for failing to meet the optimal information size. </p> </section> <section id="CD004370-sec-0066"> <h3 class="title" id="CD004370-sec-0066">Potential biases in the review process</h3> <p>Eligible studies should be readily identified by the screening process, as the terminology for 'myocarditis' and 'IVIG' are not ambiguous. Given that there is equipoise on the use of IVIG for myocarditis, studies are of great interest and are likely to be accepted for publication if the quality is acceptable. </p> </section> <section id="CD004370-sec-0067"> <h3 class="title" id="CD004370-sec-0067">Agreements and disagreements with other studies or reviews</h3> <p>A major limitation of <a href="./references#CD004370-bbs2-0003" title="McNamaraDM , HolubkovR , StarlingRC , DecGW , LohE , Torre-AmioneG , et al. Controlled trial of intravenous immune globulin in recent-onset dilated cardiomyopathy. Circulation2001;103(18):2254-9. McNamaraDM , StarlingRC , DecGW , LohE , Torre-AmioneG , GassA , et al. Intervention in myocarditis and acute cardiomyopathy with immune globulin: results from the randomized placebo controlled IMAC trial. Circulation1999;100(18):104. ">McNamara 2001</a> is that it seems likely that at least some of the trial participants may not have had viral myocarditis, as only 10 of 62 had inflammation on cardiac biopsy. However, the primary purpose of the biopsies in this trial may have been to rule out fibrosis, so fewer biopsies were taken than would have been taken had the purpose been to confirm myocarditis. This lack of benefit contrasts with multiple case reports and case series suggesting potential benefit of IVIG in suspected viral myocarditis (<a href="./references#CD004370-bbs2-0004" title="AlrabteSAH , BezantiK . Role of intravenous immunoglobulin in the treatment of acute myocarditis. Cardiology in the Young2013;2013:S96. ">Alrabate 2013</a>; <a href="./references#CD004370-bbs2-0012" title="DruckerNA , ColanSD , LewisAB , BeiserAS , WesselDL , TakahashiM , et al. Gamma-globulin treatment of acute myocarditis in the pediatric population. Circulation1994;89(1):252-7. ">Drucker 1994</a>; <a href="./references#CD004370-bbs2-0014" title="GolandS , CzerLS , SiegelRJ , TabakS , JordanS , LuthringerD , et al. Intravenous immunoglobulin treatment for acute fulminant cardiomyopathy: series of six patients and review of literature. Canadian Journal of Cardiology2008;24(7):571-4. ">Goland 2008</a>; <a href="./references#CD004370-bbs2-0016" title="HaqueA , BhattiS , SiddiquiFJ . Intravenous immune globulin for severe acute myocarditis in children. Indian Pediatrics2009;46(9):810-1. ">Haque 2009</a>; <a href="./references#CD004370-bbs2-0024" title="McNamaraDM , RosenblumWD , JanoskoKM , TrostMK , VillaneuvaFS , DemetrisAJ , et al. Intravenous immune globulin in the therapy of myocarditis and acute cardiomyopathy. Circulation1997;95(11):2476-8. ">McNamara 1997</a>; <a href="./references#CD004370-bbs2-0053" title="NigroG , BastianonV , ColloridiV , VentrigliaF , GalloP , D'AmatiG , et al. Human parvovirus B19 infection in infancy associated with acute and chronic lymphocyte myocarditis and high cytokine levels: report of 3 cases and review. Clinical Infectious Diseases2001;31(1):65-9.">Nigro 2001</a>; <a href="./references#CD004370-bbs2-0055" title="TakedaY , YasudaS , MiyazakiS , DaikokuS , NakataniS , NonogiH . High-dose immunoglobulin G therapy for fulminant myocarditis. Japanese Circulation Journal1998;62(11):871-2.">Takeda 1998</a>; <a href="./references#CD004370-bbs2-0056" title="TedeschiA , GianniniS , CiceriL , MassariFM . High-dose intravenous immunoglobulin in the treatment of acute myocarditis. A case report and review of the literature. Journal of Internal Medicine2002;251(2):169-73.">Tedeschi 2002</a>). Spontaneous improvement is common with acute myocarditis and can be rapid or gradual, so the improvement noted in these case series may have been part of the natural history of the disease. The findings from McNamara and colleagues are also incongruent with the results of the second RCT of adults with recent‐onset myocarditis that was added at this update. Kishimoto and colleagues reported longer survival times in participants treated with IVIG; however, due to an unclear risk of bias and concerns about imprecision, the certainty of the evidence was very low (<a href="./references#CD004370-bbs2-0002" title="KishimotoC , ShiojiK , HashimotoT , NonogiH , LeeJD , KatoS , et al. Therapy with immunoglobulin in patients with acute myocarditis and cardiomyopathy: analysis of leukocyte balance. Heart Vessels2014;29:336-42. ">Kishimoto 2014</a>). </p> <p>A recent review reported decreased in‐hospital mortality and improved LVEF with IVIG in 13 adult and paediatric studies with a control group (<a href="./references#CD004370-bbs2-0042" title="HuangX , SunY , SuG , LiY , ShuaiX . Intravenous immunoglobulin therapy for acute myocarditis in children and adults. International Heart Journal2019;60(2):359-65.">Huang 2019</a>). They reported improved overall survival with IVIG for acute fulminant myocarditis; however, all studies but <a href="./references#CD004370-bbs2-0001" title="El-SaiediSA . Randomized controlled trial on the use of intravenous immune globulin in acute pediatric myocarditis. Journal of Clinical Research &amp; Bioethics2013;5(1):1-5. ">El‐Saiedi 2013</a> were observational studies. It is unclear why they did not include the McNamara and Kishimoto RCTs (<a href="./references#CD004370-bbs2-0002" title="KishimotoC , ShiojiK , HashimotoT , NonogiH , LeeJD , KatoS , et al. Therapy with immunoglobulin in patients with acute myocarditis and cardiomyopathy: analysis of leukocyte balance. Heart Vessels2014;29:336-42. ">Kishimoto 2014</a>; <a href="./references#CD004370-bbs2-0003" title="McNamaraDM , HolubkovR , StarlingRC , DecGW , LohE , Torre-AmioneG , et al. Controlled trial of intravenous immune globulin in recent-onset dilated cardiomyopathy. Circulation2001;103(18):2254-9. McNamaraDM , StarlingRC , DecGW , LohE , Torre-AmioneG , GassA , et al. Intervention in myocarditis and acute cardiomyopathy with immune globulin: results from the randomized placebo controlled IMAC trial. Circulation1999;100(18):104. ">McNamara 2001</a>). </p> <p>One of the excluded studies warrants mention, as it may be of interest to the reader (<a href="./references#CD004370-bbs2-0022" title="MaischB , PankuweitS , FunckR , Koelsch. Hyperimmunoglobulin treatment is effective in CMV myocarditis - a controlled treatment trial (abstract P674). European Heart Journal2004;25(Suppl 1):114. ">Maisch 2004</a>). This was a controlled trial of cytomegalovirus hyperimmunoglobulin (CMVhlg), rather than IVIG, amongst 35 participants with CMV‐positive myocarditis. The results showed a significant difference between groups in favour of treatment in terms of elimination of CMV‐DNA and infiltrate, and improvement of 1 New York Heart Association (NYHA) class. In a review article, it was stated that data from the Marburg Registry support the notion that IVIG has efficacy for myocarditis due to adenovirus, but that for myocarditis due to parvovirus, IVIG decreases inflammation but does not eradicate the virus (<a href="./references#CD004370-bbs2-0049" title="MaischB , PankuweitS . Standard and etiology-directed evidence-based therapies in myocarditis: state of the art and future perspectives. Heart Failure Reviews2013;18(6):761-95.">Maisch 2013</a>). However, an ongoing trial in the Netherlands is examining the use of IVIG in adults with chronic cardiomyopathy and detection of parvovirus B19 on endomyocardial biopsy (<a href="./references#CD004370-bbs2-0030" title="HeymansS . Immunoglobulin therapy for patients with idiopathic cardiomyopathy and endomyocardial parvovirus B19 persistence - a prospective, double-blind, randomized, placebo-controlled clinical trial. clinicaltrials.gov/ct2/show/NCT00892112 (first received 4 May 2009). ">Heymans 2018</a>). </p> </section> </section> </section> <div class="figures-list"> <div class="figure" id="CD004370-fig-0001"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004370.pub4/media/CDSR/CD004370/urn:x-wiley:14651858:media:CD004370:CD004370-FIG-01" target="_blank"><b></b></a></p> </div><img alt="Study flow diagram." data-id="CD004370-fig-0001" src="/cdsr/doi/10.1002/14651858.CD004370.pub4/media/CDSR/CD004370/image_n/nCD004370-FIG-01.png"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004370.pub4/media/CDSR/CD004370/image_t/tCD004370-FIG-01.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 1</div> <div class="figure-caption"> <p>Study flow diagram.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004370.pub4/full#CD004370-fig-0001">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004370.pub4/media/CDSR/CD004370/image_n/nCD004370-FIG-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004370-fig-0002"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004370.pub4/media/CDSR/CD004370/urn:x-wiley:14651858:media:CD004370:CD004370-FIG-02" target="_blank"><b></b></a></p> </div><img alt="Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies." data-id="CD004370-fig-0002" src="/cdsr/doi/10.1002/14651858.CD004370.pub4/media/CDSR/CD004370/image_n/nCD004370-FIG-02.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004370.pub4/media/CDSR/CD004370/image_t/tCD004370-FIG-02.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 2</div> <div class="figure-caption"> <p>Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004370.pub4/full#CD004370-fig-0002">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004370.pub4/media/CDSR/CD004370/image_n/nCD004370-FIG-02.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004370-fig-0003"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004370.pub4/media/CDSR/CD004370/urn:x-wiley:14651858:media:CD004370:CD004370-FIG-03" target="_blank"><b></b></a></p> </div><img alt="Risk of bias summary: review authors' judgements about each risk of bias item for each included study." data-id="CD004370-fig-0003" src="/cdsr/doi/10.1002/14651858.CD004370.pub4/media/CDSR/CD004370/image_n/nCD004370-FIG-03.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004370.pub4/media/CDSR/CD004370/image_t/tCD004370-FIG-03.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 3</div> <div class="figure-caption"> <p>Risk of bias summary: review authors' judgements about each risk of bias item for each included study. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004370.pub4/full#CD004370-fig-0003">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004370.pub4/media/CDSR/CD004370/image_n/nCD004370-FIG-03.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004370-fig-0004"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004370.pub4/media/CDSR/CD004370/urn:x-wiley:14651858:media:CD004370:CD004370-CMP-001.01" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: IVIG versus placebo or no treatment in adults, Outcome 1: Event‐free survival" data-id="CD004370-fig-0004" src="/cdsr/doi/10.1002/14651858.CD004370.pub4/media/CDSR/CD004370/image_n/nCD004370-CMP-001.01.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004370.pub4/media/CDSR/CD004370/image_t/tCD004370-CMP-001.01.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.1</div> <div class="figure-caption"> <p>Comparison 1: IVIG versus placebo or no treatment in adults, Outcome 1: Event‐free survival </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004370.pub4/references#CD004370-fig-0004">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004370.pub4/media/CDSR/CD004370/image_n/nCD004370-CMP-001.01.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004370-fig-0005"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004370.pub4/media/CDSR/CD004370/urn:x-wiley:14651858:media:CD004370:CD004370-CMP-001.02" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: IVIG versus placebo or no treatment in adults, Outcome 2: Overall survival" data-id="CD004370-fig-0005" src="/cdsr/doi/10.1002/14651858.CD004370.pub4/media/CDSR/CD004370/image_n/nCD004370-CMP-001.02.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004370.pub4/media/CDSR/CD004370/image_t/tCD004370-CMP-001.02.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.2</div> <div class="figure-caption"> <p>Comparison 1: IVIG versus placebo or no treatment in adults, Outcome 2: Overall survival</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004370.pub4/references#CD004370-fig-0005">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004370.pub4/media/CDSR/CD004370/image_n/nCD004370-CMP-001.02.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004370-fig-0006"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004370.pub4/media/CDSR/CD004370/urn:x-wiley:14651858:media:CD004370:CD004370-CMP-001.03" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: IVIG versus placebo or no treatment in adults, Outcome 3: Change in LVEF" data-id="CD004370-fig-0006" src="/cdsr/doi/10.1002/14651858.CD004370.pub4/media/CDSR/CD004370/image_n/nCD004370-CMP-001.03.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004370.pub4/media/CDSR/CD004370/image_t/tCD004370-CMP-001.03.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.3</div> <div class="figure-caption"> <p>Comparison 1: IVIG versus placebo or no treatment in adults, Outcome 3: Change in LVEF </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004370.pub4/references#CD004370-fig-0006">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004370.pub4/media/CDSR/CD004370/image_n/nCD004370-CMP-001.03.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004370-fig-0007"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004370.pub4/media/CDSR/CD004370/urn:x-wiley:14651858:media:CD004370:CD004370-CMP-001.04" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: IVIG versus placebo or no treatment in adults, Outcome 4: Peak oxygen consumption" data-id="CD004370-fig-0007" src="/cdsr/doi/10.1002/14651858.CD004370.pub4/media/CDSR/CD004370/image_n/nCD004370-CMP-001.04.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004370.pub4/media/CDSR/CD004370/image_t/tCD004370-CMP-001.04.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.4</div> <div class="figure-caption"> <p>Comparison 1: IVIG versus placebo or no treatment in adults, Outcome 4: Peak oxygen consumption </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004370.pub4/references#CD004370-fig-0007">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004370.pub4/media/CDSR/CD004370/image_n/nCD004370-CMP-001.04.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004370-fig-0008"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004370.pub4/media/CDSR/CD004370/urn:x-wiley:14651858:media:CD004370:CD004370-CMP-001.05" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: IVIG versus placebo or no treatment in adults, Outcome 5: Side effects" data-id="CD004370-fig-0008" src="/cdsr/doi/10.1002/14651858.CD004370.pub4/media/CDSR/CD004370/image_n/nCD004370-CMP-001.05.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004370.pub4/media/CDSR/CD004370/image_t/tCD004370-CMP-001.05.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.5</div> <div class="figure-caption"> <p>Comparison 1: IVIG versus placebo or no treatment in adults, Outcome 5: Side effects</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004370.pub4/references#CD004370-fig-0008">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004370.pub4/media/CDSR/CD004370/image_n/nCD004370-CMP-001.05.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004370-fig-0009"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004370.pub4/media/CDSR/CD004370/urn:x-wiley:14651858:media:CD004370:CD004370-CMP-001.06" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: IVIG versus placebo or no treatment in adults, Outcome 6: Failure to attain complete recovery" data-id="CD004370-fig-0009" src="/cdsr/doi/10.1002/14651858.CD004370.pub4/media/CDSR/CD004370/image_n/nCD004370-CMP-001.06.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004370.pub4/media/CDSR/CD004370/image_t/tCD004370-CMP-001.06.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.6</div> <div class="figure-caption"> <p>Comparison 1: IVIG versus placebo or no treatment in adults, Outcome 6: Failure to attain complete recovery </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004370.pub4/references#CD004370-fig-0009">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004370.pub4/media/CDSR/CD004370/image_n/nCD004370-CMP-001.06.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004370-fig-0010"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004370.pub4/media/CDSR/CD004370/urn:x-wiley:14651858:media:CD004370:CD004370-CMP-002.01" target="_blank"><b></b></a></p> </div><img alt="Comparison 2: IVIG versus placebo or no treatment in children, Outcome 1: Overall survival" data-id="CD004370-fig-0010" src="/cdsr/doi/10.1002/14651858.CD004370.pub4/media/CDSR/CD004370/image_n/nCD004370-CMP-002.01.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004370.pub4/media/CDSR/CD004370/image_t/tCD004370-CMP-002.01.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.1</div> <div class="figure-caption"> <p>Comparison 2: IVIG versus placebo or no treatment in children, Outcome 1: Overall survival </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004370.pub4/references#CD004370-fig-0010">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004370.pub4/media/CDSR/CD004370/image_n/nCD004370-CMP-002.01.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004370-fig-0011"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004370.pub4/media/CDSR/CD004370/urn:x-wiley:14651858:media:CD004370:CD004370-CMP-002.02" target="_blank"><b></b></a></p> </div><img alt="Comparison 2: IVIG versus placebo or no treatment in children, Outcome 2: Change in LVEDD" data-id="CD004370-fig-0011" src="/cdsr/doi/10.1002/14651858.CD004370.pub4/media/CDSR/CD004370/image_n/nCD004370-CMP-002.02.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004370.pub4/media/CDSR/CD004370/image_t/tCD004370-CMP-002.02.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.2</div> <div class="figure-caption"> <p>Comparison 2: IVIG versus placebo or no treatment in children, Outcome 2: Change in LVEDD </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004370.pub4/references#CD004370-fig-0011">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004370.pub4/media/CDSR/CD004370/image_n/nCD004370-CMP-002.02.svg" target="_blank">Open in new tab</a></div> </div> </div> <div class="tables-list"> <div class="table"> <table class="summary-of-findings framed" data-id="CD004370-tbl-0001"> <div class="table-heading"><span class="table-label">Summary of findings 1.</span> <span class="table-title">Intravenous immunoglobulin compared with placebo or no treatment for adults with acute myocarditis</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Intravenous immunoglobulin compared with placebo or no treatment for adults with acute myocarditis</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Patient or population:</b> adults with acute myocarditis </p> <p><b>Settings:</b> hospital </p> <p><b>Intervention:</b> IVIG </p> <p><b>Comparison:</b> placebo or no treatment </p> </td> </tr> <tr class="separated"> <th align="left" class="headercell" colspan="1" rowspan="3" scope="col" valign="bottom"> <p><b>Outcomes</b> </p> </th> <th align="left" class="headercell table-tint" colspan="2" rowspan="1" scope="col" valign="bottom"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="3" scope="col" valign="bottom"> <p><b>Relative effect<br/>(95% CI)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="3" scope="col" valign="bottom"> <p><b>Number of participants<br/>(studies)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="3" scope="col" valign="bottom"> <p><b>Certainty of the evidence<br/>(GRADE)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="3" scope="col" valign="bottom"> <p><b>Comments</b> </p> </th> </tr> <tr class="separated"> <th align="left" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Assumed risk</b> </p> </th> <th align="left" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Corresponding risk</b> </p> </th> </tr> <tr class="separated"> <th align="left" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Control</b> </p> </th> <th align="left" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>IVIG</b> </p> </th> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Event‐free survival (risk of death, cardiac transplant, or left ventricular assist device) ‐ adults with myocarditis, median follow‐up of 23 months </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>103 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>182 per 1000</p> <p>(50 to 662)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>RR 1.76 (0.48 to 6.40)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>62 (1)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/><b>Very low</b><sup>1,2,3</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Overall survival (risk of death) ‐ adults with myocarditis, median follow‐up of 3.5 months </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>182 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>165 per 1000</p> <p>(42 to 658)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>RR 0.91 (0.23 to 3.62)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>103 (2)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/><b>Very low</b><sup>1,3,4</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Side effects ‐ mild infusion effects, 12‐month follow‐up</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>0 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>2 per 1000</p> <p>(0 to 33)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>RR 20.29 (1.25 to 329.93)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>62 (1)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝</p> <p><b>Very low</b><sup>1,5,6</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No control participants reported side effects; baseline risk was estimated to be 0.01% based on the limited data available. For the data reported NNTH = 3. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*Basis for assumed risk was calculated by the number of events in the control group reported for each survival outcome. For side effects, no events were reported in the control group. To estimate baseline risk we assumed a low baseline risk of 0.01% based on the limited data available for that outcome. The <b>corresponding risk</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI). </p> <p><b>CI:</b> confidence interval; <b>IVIG:</b> intravenous immunoglobulin; <b>NNTH</b> : number needed to treat for an additional harmful outcome; <b>RR:</b> risk ratio </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/><b>High certainty:</b> Further research is very unlikely to change our confidence in the estimate of effect.<br/><b>Moderate certainty:</b> Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.<br/><b>Low certainty:</b> Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.<br/><b>Very low certainty:</b> We are very uncertain about the estimate. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup>Downgraded by 1 level due to unclear risk of bias related to lack of clarity around randomisation and blinding.<br/><sup>2</sup>Downgraded by 1 level for indirectness as very few participants had proven myocarditis.<br/><sup>3</sup>Downgraded by 2 levels for imprecision due to optimal information size not being met and CI including both appreciable benefit and harm.<br/><sup>4</sup>Downgraded by 1 level for indirectness as it was it was unclear if biopsies were done to confirm myocarditis and rule out congential cardiomyopathies.<br/><sup>5</sup>Downgraded by 1 level for indirectness due to uncertainty of the baseline estimate.<br/><sup>6</sup>Downgraded by 1 level for imprecision due to optimal information size not being met and large CI. </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings 1.</span> <span class="table-title">Intravenous immunoglobulin compared with placebo or no treatment for adults with acute myocarditis</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD004370.pub4/full#CD004370-tbl-0001">Navigate to table in review</a></div> </div> <div class="table"> <table class="summary-of-findings framed" data-id="CD004370-tbl-0002"> <div class="table-heading"><span class="table-label">Summary of findings 2.</span> <span class="table-title">Intravenous immunoglobulin compared with placebo or no treatment for children with acute myocarditis</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p><b>Intravenous immunoglobulin compared with placebo or no treatment for children with acute myocarditis</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p><b>Patient or population:</b> children with acute myocarditis </p> <p><b>Settings:</b> hospital </p> <p><b>Intervention:</b> IVIG </p> <p><b>Comparison:</b> placebo or no treatment </p> </td> </tr> <tr class="separated"> <th align="left" class="headercell" colspan="1" rowspan="3" scope="col" valign="bottom"> <p><b>Outcomes</b> </p> </th> <th align="left" class="headercell table-tint" colspan="2" rowspan="1" scope="col" valign="bottom"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="3" scope="col" valign="bottom"> <p><b>Relative effect<br/>(95% CI)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="3" scope="col" valign="bottom"> <p><b>Number of participants<br/>(studies)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="3" scope="col" valign="bottom"> <p><b>Certainty of the evidence<br/>(GRADE)</b> </p> </th> </tr> <tr class="separated"> <th align="left" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Assumed risk</b> </p> </th> <th align="left" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Corresponding risk</b> </p> </th> </tr> <tr class="separated"> <th align="left" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Control</b> </p> </th> <th align="left" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>IVIG</b> </p> </th> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Overall survival (risk of death) ‐ children with myocarditis, 6‐month follow‐up</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>295 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>142 per 1000</p> <p>(59 to 340)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>RR 0.48 (0.20 to 1.15)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>86 (1)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/><b>Very low</b><sup>1,2</sup> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p>*Basis for assumed risk was calculated by the number of events in the control group reported for each survival outcome. The <b>corresponding risk</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI). </p> <p><b>CI:</b> confidence interval; <b>IVIG:</b> intravenous immunoglobulin; <b>RR:</b> risk ratio </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/><b>High certainty:</b> Further research is very unlikely to change our confidence in the estimate of effect.<br/><b>Moderate certainty:</b> Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.<br/><b>Low certainty:</b> Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.<br/><b>Very low certainty:</b> We are very uncertain about the estimate. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="6"> <div class="table-footnote"> <p><sup>1</sup>Downgraded by 2 levels for imprecision due to optimal information size not being met and CI including both appreciable benefit and harm.<br/><sup>2</sup>Downgraded by 1 level for indirectness as it was it was unclear if biopsies were done to confirm myocarditis and rule out congential cardiomyopathies. </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings 2.</span> <span class="table-title">Intravenous immunoglobulin compared with placebo or no treatment for children with acute myocarditis</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD004370.pub4/full#CD004370-tbl-0002">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD004370-tbl-0003"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">IVIG versus placebo or no treatment in adults</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.1 Event‐free survival <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>62</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.76 [0.48, 6.40]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.2 Overall survival <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>103</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.91 [0.23, 3.62]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.3 Change in LVEF <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>103</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.01 [‐0.06, 0.05]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.4 Peak oxygen consumption <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>48</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.80 [‐4.57, 2.97]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.5 Side effects <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>62</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>20.29 [1.25, 329.93]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.6 Failure to attain complete recovery <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>41</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.46 [0.19, 1.14]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">IVIG versus placebo or no treatment in adults</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD004370.pub4/references#CD004370-tbl-0003">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD004370-tbl-0004"> <div class="table-heading"><span class="table-label">Comparison 2.</span> <span class="table-title">IVIG versus placebo or no treatment in children</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2.1 Overall survival <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>86</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.48 [0.20, 1.15]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2.2 Change in LVEDD <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>86</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐4.00 [‐9.52, 1.52]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 2.</span> <span class="table-title">IVIG versus placebo or no treatment in children</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD004370.pub4/references#CD004370-tbl-0004">Navigate to table in review</a></div> </div> </div> <noscript> <img height="1" src="/scolaris-auth/report/nonjs/fulltexthtmlreg?doi=10.1002%2F14651858.CD004370.pub4&amp;rf=&amp;articleType=CDSR" style="display:none" width="1"> </img></noscript> <section class="translation-notes-modal" data-modal-class="translation-notes" data-modal-title="Translation notes" data-ok-btn-selector=".ok-btn" style="display: none"> <div class="translation-notes"> <div class="section-language-toggles"> <nav class="section-languages"> <ul> <li class="section-languages-legend">Available in</li> <li class="section-language"> <a class="" href="es#CD004370-note-0012">Español</a> </li> <li class="section-language"> <a class="" href="fa#CD004370-note-0011">فارسی</a> </li> <li class="section-language"> <a class="" href="hr#CD004370-note-0010">Hrvatski</a> </li> <li class="section-language"> <a class="" href="ko#CD004370-note-0008">한국어</a> </li> <li class="section-language"> <a class="" href="ms#CD004370-note-0009">Bahasa Malaysia</a> </li> <li class="section-language"> <a class="" href="ru#CD004370-note-0007">Русский</a> </li> <li class="section-language"> <a class="" href="zh_HANS#CD004370-note-0005">简体中文</a> </li> <li class="section-language"> <a class="" href="zh_HANT#CD004370-note-0006">繁體中文</a> </li> </ul> </nav> </div> <section class="translation-notes-content"> </section> <button class="btn primary ok-btn pull-right" type="button">Close</button> </div> </section></article> </div> <div class="citation-modal" style="display: none"> <div class="export-citation-header"> <p class="inset-message" data-load-error="Unable to load citation data" id="citeProcText"></p> </div> <div class="export-citation-body row-fluid"> <div class="span12"> <div class="addthis_toolbox addthis_default_style addthis_16x16_style"> <nav class="inline-nav-list is-bordered"> <li> <h4 class="heading">Save citation to:</h4> </li> <li><a class="citation-btn-refworks at300b btn btn-link" href="#" id="refWorksCitationBtn"><span class="citation-icon refworks"></span>RefWorks</a></li> <li><a class="citation-btn-sciwheel at300b btn btn-link disabled" href="#" id="sciWheelCitationBtn" target="_blank"><span class="citation-icon sciwheel"></span>SciWheel</a></li> </nav> </div> </div> </div> <div class="row-fluid"> <div class="span12"> <div class="citation-format"> <h4>Copy or download citation</h4> <a href="/en/help/exporting-search-results" rel="noopener noreferrer" target="_blank">Export help</a> </div> <nav class="inline-nav-list has-dividers"> <li class="citation-option" data-option="plain"><button class="btn btn-link" type="button">Plain text</button></li> <li class="citation-option" data-option="endnote"><button class="btn btn-link" type="button">EndNote</button></li> <li class="citation-option" data-option="refmanager"><button class="btn btn-link" type="button">Reference Manager</button></li> <li class="citation-option" data-option="procite"><button class="btn btn-link" type="button">ProCite</button></li> <li class="citation-option" data-option="bibtex"><button class="btn btn-link" type="button">BibteX</button></li> <li class="citation-option" data-option="csv"><button class="btn btn-link" type="button">CSV (Excel)</button></li> </nav> <div class="citation-content"> <pre data-load-error="Unable to load citation data" id="citationContent" tabindex="0"></pre> </div> <div class="clearfix"> <form class="download-citation-form" data-citation-citeproc-url="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=citation-citeproc&amp;p_p_cacheability=cacheLevelPage&amp;p_p_col_id=column-1&amp;p_p_col_count=1" method="GET" target="citation-download-iframe"> <input id="siteId" name="siteId" type="hidden" value=""> <input id="downloadType" name="downloadType" type="hidden" value=""> <input id="style" name="style" type="hidden" value=""> <input id="articleId" name="articleId" type="hidden" value=""> <input name="p_p_id" type="hidden" value="scolariscontentdisplay_WAR_scolariscontentdisplay"><input name="p_p_lifecycle" type="hidden" value="2"><input name="p_p_state" type="hidden" value="normal"><input name="p_p_mode" type="hidden" value="view"/><input name="p_p_resource_id" type="hidden" value="citation-download"/><input name="p_p_cacheability" type="hidden" value="cacheLevelPage"/><input name="p_p_col_id" type="hidden" value="column-1"/><input name="p_p_col_count" type="hidden" value="1"/> <button class="btn primary wide pull-right" type="submit">Download</button> <div class="inline-checkbox pull-right"> <label title=" for=" withabstract"=""> <input checked="" class="checkbox" name="withAbstract" type="checkbox"/> <span class="checkbox-label">Include abstract</span> </label> </div> </input></input></input></input></input></input></input></form> <iframe aria-hidden="true" name="citation-download-iframe" src="" style="display: none; visibility: hidden" title="Citation download frame"></iframe> </div> </div> </div> </div> <div class="print-modal" data-modal-title="Print this review" style="display: none;"> <div class="print-options-wrapper"> <p><strong>All sections are selected by default</strong>, please select the sections you do not wish to print or use the select or deselect all button to add or remove sections.</p> <div class="print-options-controls"> <input checked="checked" class="print-options-select-all" title="Select/deselect all" type="checkbox"/> <span class="checkbox-label">Select/deselect all</span> </div> <ul class="print-options checkbox-list"> </ul> <button class="btn primary print-article pull-right"><i aria-hidden="true" class="fa fa-print"></i> Print</button> </div> </div> <div class="download-stats-data-modal" data-modal-title="Download data package" style="display: none;"> <div> <p> The data available are protected by copyright and may only be used in accordance with the <a class="external" href="/about/data-download" target="_blank">Terms and Conditions.</a> </p> <div class="hide-for-zip"> <p> <a class="external" href="https://revman.cochrane.org/#/rm5Converter" target="_blank">RevMan 5 files</a> can be converted to a <a class="external" href="https://links.cochrane.org/review-datapack-userguide" target="_blank">data package.</a> </p> </div> <p> Files in the data package can be imported to <a class="external" href="https://revman.cochrane.org/info" target="_blank">Review Manager software</a> or opened in other tools that support CSV and RIS. </p> <form class="download-stats-data-form" method="GET" target="_blank"> <input name="content-disposition" type="hidden" value="attachment"/> <input name="mime-type" type="hidden" value="application/octet-stream"/> <p class="print-options-controls"> <input aria-label="I agree to these terms and conditions" class="download-stats-data-toc-check-box" type="checkbox"/> <span aria-hidden="true" class="checkbox-label">I agree to these terms and conditions</span> <button class="btn primary download-stats-data pull-right" disabled=""><i aria-hidden="true" class="fa fa-download"></i> Download data</button> </p> </form> </div> </div> <div class="share-modal" data-modal-title="Share this review" style="display:none;"> </div> <div class="viewer-thumbnail-pane-html" style="display:none;"> <div class="figure-viewer-options"> <nav class="inline-nav-list"> <li class="figure-options-btn-container"><button class="btn btn-link" id="figureOptionBtn" type="button">Figures</button></li> <li class="table-options-btn-container"><button class="btn btn-link" id="tableOptionBtn" type="button">Tables</button></li> </nav> </div> <div class="figure-viewer-thumbnails"> <div class="figure-thumbnails is-visible" id="figureThumbnails"></div> <div class="table-thumbnails" id="tableThumbnails"></div> </div> </div> <div class="utilities-html" style="display:none;"> <div class="figure-viewer-utilities"> <a class="figure-viewer-menu-toggle" href="#"> <i class="fa fa-chevron-left"></i><span class="toggle-label" data-figure-hide-text="Hide thumbnails" data-figure-show-text="Show thumbnails" data-table-hide-text="Hide table list" data-table-show-text="Show table list">Hide thumbnails</span> </a> <a class="figure-viewer-navigateback" href="#"> <i class="fa fa-chevron-left"></i> </a> <a class="figure-viewer-rotate" href="#"> <i class="fa fa-undo"></i> </a> <a class="figure-viewer-download" href="#"> <i class="fa fa-download"></i> </a> <a class="figure-viewer-share" href="#"> <i class="fa fa-share-alt"></i> </a> <a class="figure-viewer-zoomin" href="#"> <i class="fa fa-plus"></i><span>zoom in</span> </a> <a class="figure-viewer-zoomout" href="#"> <i class="fa fa-minus"></i><span>zoom out</span> </a> </div> </div> <div class="controls-html" style="display:none;"> <div class="figure-viewer-navigation"> <a class="figure-viewer-nav previous" href="#"> <i class="fa fa-chevron-left"></i><span>left</span> </a> <a class="figure-viewer-nav next" href="#"> <i class="fa fa-chevron-right"></i><span>right</span> </a> </div> </div> <div class="mobile-thumbnail-selector-html" style="display:none;"> <div class="figure-viewer-mobile-thumbnails"> <select class="figure-selection"> <option>Figures</option> </select> <select class="table-selection"> <option>Tables</option> </select> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div>
<div class="portlet-boundary portlet-boundary_1_WAR_kaleodesignerportlet_ portlet-static portlet-static-end kaleo-designer-portlet" id="p_p_id_1_WAR_kaleodesignerportlet_">
<span id="p_1_WAR_kaleodesignerportlet"></span>
</div>
<form action="#" id="hrefFm" method="post" name="hrefFm">
<span></span>
</form>
</div>
<footer class="footer">
<div class="main-footer">
<div class="main-footer-wrapper container">
<div class="brand">
<p class="brand-name">Cochrane</p>
<a href="http://www.cochrane.org/" title="Cochrane logo">
<img alt="Cochrane logo" class="footer-logo logo-part-1" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-1.png"> <img alt="" class="footer-logo logo-part-2" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-2.png"> </img></img></a> </div> </div> </div> <div class="aux-footer"> <div class="aux-footer-nav-container container"> <nav class="aux-footer-nav"> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse Publications</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse by Subject</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/advertisers">Advertisers &amp; Agents</a></li> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Contact Us</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Help &amp; Support</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/terms-and-conditions">Terms &amp; Conditions</a></li> </ul> </nav> </div> <div class="brand"> <div class="brand-container container"> <p class="copyright"> Copyright © 2000 - 2025 by <a class="" href="http://www.wiley.com">John Wiley &amp; Sons, Inc.</a> All Rights Reserved <br> Review our <a href="https://www.wiley.com/privacy"><strong>Privacy Policy</strong></a> <a href="https://www.wiley.com/cookies"><strong>Cookie Policy</strong></a> <a href="#" onclick="Osano.cm.showDrawer('osano-cm-dom-info-dialog-open')"><strong>Cookie Preferences</strong></a> </br></p> <a href="http://eu.wiley.com/"><img alt="Wiley logo" class="logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_wiley-footer-logo.png"/></a> </div> </div> <span class="wiley-semi-circle"></span> </div> <!--BEGIN QUALTRICS WEBSITE FEEDBACK SNIPPET--> <script type="text/javascript"> (function(){var g=function(e,h,f,g){ this.get=function(a){for(var a=a+"=",c=document.cookie.split(";"),b=0,e=c.length;b<e;b++){for(var d=c[b];" "==d.charAt(0);)d=d.substring(1,d.length);if(0==d.indexOf(a))return d.substring(a.length,d.length)}return null}; this.set=function(a,c){var b="",b=new Date;b.setTime(b.getTime()+6048E5);b="; expires="+b.toGMTString();document.cookie=a+"="+c+b+"; path=/; "}; this.check=function(){var a=this.get(f);if(a)a=a.split(":");else if(100!=e)"v"==h&&(e=Math.random()>=e/100?0:100),a=[h,e,0],this.set(f,a.join(":"));else return!0;var c=a[1];if(100==c)return!0;switch(a[0]){case "v":return!1;case "r":return c=a[2]%Math.floor(100/c),a[2]++,this.set(f,a.join(":")),!c}return!0}; this.go=function(){if(this.check()){var a=document.createElement("script");a.type="text/javascript";a.src=g;document.body&&document.body.appendChild(a)}}; this.start=function(){var t=this;"complete"!==document.readyState?window.addEventListener?window.addEventListener("load",function(){t.go()},!1):window.attachEvent&&window.attachEvent("onload",function(){t.go()}):t.go()};}; try{(new g(100,"r","QSI_S_ZN_cGCHHvWNpnJb1zf","https://zncgchhvwnpnjb1zf-wiley.siteintercept.qualtrics.com/SIE/?Q_ZID=ZN_cGCHHvWNpnJb1zf")).start()}catch(i){}})(); </script><div id="ZN_cGCHHvWNpnJb1zf"><!--DO NOT REMOVE-CONTENTS PLACED HERE--></div> <!--END WEBSITE FEEDBACK SNIPPET--> </footer> <div class="scolaris-modal-overlay"></div> <div class="scolaris-modal"> <div class="scolaris-modal-titlebar clearfix"> <p class="scolaris-modal-title"></p> <a class="scolaris-modal-close" href="#"><span>close</span><span class="icon fa fa-times"></span></a> <div class="scolaris-modal-ui"></div> </div> <!-- Static injection of addtoAny as dynamic injection not working properly--> <div class="scolaris-share-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"> <div class="a2a_kit a2a_kit_size_32 a2a_default_style"> <a class="a2a_button_facebook share-button">  Facebook</a> <a class="a2a_button_x share-button">  X(Twitter)</a> <a class="a2a_button_whatsapp share-button">  WhatsApp</a> <a class="a2a_dd share-button">  View more</a> </div> </div> </div> <div class="scolaris-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="english-only-modal-wrapper" data-modal-class="english-only-modal" data-modal-title="Feature in English only" style="display: none"> <div class="english-only-modal"> <p class="message"></p> <button class="btn primary ok-btn pull-right" type="button">OK</button> <button class="btn primary border-only cancel-btn pull-right" type="button">Cancel</button> </div> </div> <!--[if gte IE 9]><!--> <script src="/cochrane-theme/vendor/ie9.js?t=1738734739000" type="text/javascript"></script> <!--<![endif]--> <script src="https://www.cochranelibrary.com/cochrane-theme/js/theme.js?t=1738734739000" type="text/javascript"></script> <script src="https://content.readcube.com/cochrane/checkout.js"></script> <script src="https://content.readcube.com/cochrane/epdf_linker.js" type="text/javascript"></script> <script src="https://crossmark-cdn.crossref.org/widget/v2.0/widget.js" type="text/javascript"></script> <script src="https://d1bxh8uas1mnw7.cloudfront.net/assets/embed.js" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/hit-highlighting.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/topics-lookup.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/institution.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/api-manager.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/pico.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/reference-linking.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/rightsLink.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.submit.failed.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.comment.form.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/safety-alerts.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.translation-notes-modal.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/notifications-portlet/notifications/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-search/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773542000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-topics/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-language-portlet/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773471000" type="text/javascript"></script> <script type="text/javascript">Liferay.Util.addInputFocus();</script> <script type="text/javascript">Liferay.Portlet.register("scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_",portletId:"scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD004370\x2epub4\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD004370\x2epub4\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD004370\x2epub4\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD004370\x2epub4"});Liferay.Portlet.register("scolariscontentdisplay_WAR_scolariscontentdisplay");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_",portletId:"scolariscontentdisplay_WAR_scolariscontentdisplay",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentdisplay_WAR_scolariscontentdisplay\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dcolumn-1\x26p_p_col_pos\x3d0\x26p_p_col_count\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD004370\x2epub4\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD004370\x2epub4\x2526type\x253Dcdsr\x2526contentLanguage\x253D"});Liferay.provide(Liferay.Util,"openKaleoDesignerPortlet",function(c){var b=AUI();var e=Liferay.PortletURL.createURL("https://www.cochranelibrary.com/en/content?p_p_id=2_WAR_kaleodesignerportlet&p_p_lifecycle=0");e.setParameter("mvcPath","/designer/edit_kaleo_draft_definition.jsp");e.setParameter("availableFields",c.availableFields);e.setParameter("availablePropertyModels",c.availablePropertyModels);e.setParameter("ddmStructureId",c.ddmStructureId);e.setParameter("draftVersion",c.draftVersion);e.setParameter("kaleoProcessId",c.kaleoProcessId);e.setParameter("name",c.name);e.setParameter("openerWindowName",c.openerWindowName);e.setParameter("portletResourceNamespace",c.portletResourceNamespace);e.setParameter("propertiesSaveCallback",c.propertiesSaveCallback);e.setParameter("refreshOpenerOnClose",c.refreshOpenerOnClose);e.setParameter("saveCallback",c.saveCallback);e.setParameter("version",c.version);e.setWindowState("pop_up");c.uri=e.toString();var d=c.dialog;if(!d){var f=b.one(Liferay.Util.getOpener()).get("region");d={destroyOnHide:true};c.dialog=d}if(!("align" in d)){d.align=Liferay.Util.Window.ALIGN_CENTER}var a=c.dialogIframe;if(!a){a={closeOnEscape:false};c.dialogIframe=a}Liferay.Util.openWindow(c)},["liferay-portlet-url"]);Liferay.Portlet.register("1_WAR_kaleodesignerportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_1_WAR_kaleodesignerportlet_",portletId:"1_WAR_kaleodesignerportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3d1_WAR_kaleodesignerportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD004370\x2epub4\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD004370\x2epub4\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD004370\x2epub4\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD004370\x2epub4"});Liferay.Portlet.register("scolarissearchportlet_WAR_scolarissearch");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarissearchportlet_WAR_scolarissearch_",portletId:"scolarissearchportlet_WAR_scolarissearch",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarissearchportlet_WAR_scolarissearch\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD004370\x2epub4\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD004370\x2epub4\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD004370\x2epub4\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD004370\x2epub4"});Liferay.Portlet.register("scolariscontentlanguagebanner_WAR_scolarislanguageportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_",portletId:"scolariscontentlanguagebanner_WAR_scolarislanguageportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentlanguagebanner_WAR_scolarislanguageportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD004370\x2epub4\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD004370\x2epub4\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD004370\x2epub4\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD004370\x2epub4"});AUI().use("aui-base","liferay-menu","liferay-notice","liferay-poller","liferay-session",function(a){(function(){Liferay.Util.addInputType();Liferay.Portlet.ready(function(b,c){Liferay.Util.addInputType(c)});if(a.UA.mobile){Liferay.Util.addInputCancel()}})();(function(){new Liferay.Menu();var b=Liferay.Data.notices;for(var c=1;c<b.length;c++){new Liferay.Notice(b[c])}})();(function(){Liferay.Session=new Liferay.SessionBase({autoExtend:true,sessionLength:1800,redirectOnExpire:false,redirectUrl:"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane",warningLength:0})})()});</script> <script src="https://www.cochranelibrary.com/cochrane-theme/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1738734739000" type="text/javascript"></script> <script type="text/javascript"></script> <div class="mobile-righthand-nav"> <a class="rh-nav-close-btn" href="#"> <span>Close</span> <span class="fa fa-chevron-down"></span> </a> <div class="wrapper"> </div> <a class="rh-nav-open-btn" href="#"> <span>Review tools &amp; navigation</span> </a> </div> <iframe aria-hidden="true" id="printframe" name="printframe" style="position: absolute; left: -2000px; top: 0;" title="Print frame"></iframe> <iframe aria-hidden="true" id="citationExportFrame" name="citationExportFrame" style="position: absolute; left: -2000px; top: 0;" title="scolaris.citation.export.frame"></iframe> <nav> <div class="mobile-navigation"> <div class="close-container"> <a aria-label="Navigate back" class="main-nav-back-btn" href="#"><i class="fa fa-chevron-left"></i></a> <a class="main-nav-close-btn" href="#" title="Close menu">Close menu <i class="fa fa-times"></i></a> </div> <div class="mobile-search basic-search-container"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="ymag__null__null" src="/scolaris-search/icon.png"> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </img></span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=WbpyPs9C&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"> <input name="facetDisplayName" type="hidden" value=""> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</input></input></form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD004370.pub4&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD004370.pub4';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<a class="btn secondary" href="/en/browse-by-topic">Browse </a>
<a class="btn secondary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
<div class="menu-items parent">
<div>
<div class="nav-root-item parent">
<a class="language-selection-title-link" href="#" title="Select language">
<span class="mobile-nav-language-title">Select your preferred language </span></a> <span class="icon fa fa-caret-down"></span>
<div class="mob-child">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="fdkn__null__null" src="/scolaris-language-portlet/icon.png"> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </img></span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> English </a> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> English </a> </div> <div class="form-content language-selector-modal child"> <div class="row-fluid"> <h3><i class="fa fa-file-text"></i> Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> <div class="dropdown-trigger" id="active-content-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="content-language-selector" data-languagecode="de" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=de">Deutsch</a> <a class="content-language-selector is-active" data-languagecode="en" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=en">English</a> <a class="content-language-selector" data-languagecode="es" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=es">Español</a> <a class="content-language-selector" data-languagecode="fa" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fa">فارسی</a> <a class="content-language-selector" data-languagecode="fr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fr">Français</a> <a class="content-language-selector" data-languagecode="hi" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hi">हिन्दी</a> <a class="content-language-selector" data-languagecode="hr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hr">Hrvatski</a> <a class="content-language-selector" data-languagecode="id" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=id">Bahasa Indonesia</a> <a class="content-language-selector" data-languagecode="ja" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ja">日本語</a> <a class="content-language-selector" data-languagecode="ko" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ko">한국어</a> <a class="content-language-selector" data-languagecode="hu" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hu">Magyar</a> <a class="content-language-selector" data-languagecode="ms" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ms">Bahasa Malaysia</a> <a class="content-language-selector" data-languagecode="nl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=nl">Nederlands</a> <a class="content-language-selector" data-languagecode="pl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pl">Polski</a> <a class="content-language-selector" data-languagecode="pt" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pt">Português</a> <a class="content-language-selector" data-languagecode="ru" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ru">Русский</a> <a class="content-language-selector" data-languagecode="ro" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ro">Română</a> <a class="content-language-selector" data-languagecode="ta" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ta">தமிழ்</a> <a class="content-language-selector" data-languagecode="th" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=th">ภาษาไทย</a> <a class="content-language-selector" data-languagecode="zh_HANT" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANT">繁體中文</a> <a class="content-language-selector" data-languagecode="zh_HANS" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANS">简体中文</a> </div> </div> <div class="row-fluid"> <h3 class="portal-language-header"><i class="fa fa-globe"></i> Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> <div class="dropdown-trigger" id="active-portal-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="portal-language-selector is-active" data-portallanguage="en" href="/en/cdsr/doi/10.1002/14651858.CD004370.pub4/full/en">English</a> <a class="portal-language-selector" data-portallanguage="es" href="/es/cdsr/doi/10.1002/14651858.CD004370.pub4/full/es">Español</a> </div> </div> <a class="btn secondary ok-btn pull-right" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
<div class="parent">
<a class="mobile-link signin" data-redirect="false" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD004370.pub4%2Ffull" rel="nofollow">
                        Sign In
                    </a>
</div>
</div>
<div class="menu-items-footer">
<div class="utility-links">
<a class="cochrane-link" href="http://www.cochrane.org/" target="_blank">Visit Cochrane.org</a>
</div>
</div>
</div>
<div class="menu-items child"></div>
</div>
</nav><div class="basic-login-form-content" data-modal-title="Sign in" style="display: none;">
<div class="form-content">
<div class="row-fluid">
<div class="span12">
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_MODAL_">
<span id="p_58_INSTANCE_MODAL"></span>
<section class="portlet" id="portlet_58_INSTANCE_MODAL">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="dbam__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_MODAL" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_MODAL&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_MODAL_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_MODAL_fm" method="post" name="_58_INSTANCE_MODAL_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_MODAL_formDate" type="hidden" value="1740724988744"> <input class="field" id="_58_INSTANCE_MODAL_saveLastPath" name="_58_INSTANCE_MODAL_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_MODAL_redirect" name="_58_INSTANCE_MODAL_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD004370.pub4/full"> <input class="field" id="_58_INSTANCE_MODAL_doActionAfterLogin" name="_58_INSTANCE_MODAL_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_login"> Email Address </label> <input class="field clearable" id="_58_INSTANCE_MODAL_login" name="_58_INSTANCE_MODAL_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_password"> Password </label> <input class="field" id="_58_INSTANCE_MODAL_password" name="_58_INSTANCE_MODAL_password" type="password" value=""/> </div> <span id="_58_INSTANCE_MODAL_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="clearfix"> <div class="checkbox-list pull-left"> <div class="checkbox-list-item"> <div class="control-group form-inline input-checkbox-wrapper"> <label for="_58_INSTANCE_MODAL_rememberMeCheckbox"> <input id="_58_INSTANCE_MODAL_rememberMe" name="_58_INSTANCE_MODAL_rememberMe" type="hidden" value="true"/> <input checked="" class="field" id="_58_INSTANCE_MODAL_rememberMeCheckbox" name="_58_INSTANCE_MODAL_rememberMeCheckbox" onclick="Liferay.Util.updateCheckboxValue(this); " type="checkbox" value="true"/> Remember Me </label> </div> </div> </div> <div class="pull-right"> <a href="https://onlinelibrary.wiley.com/user/forgottenpassword" target="_blank">Forgotten password?</a> </div> </div> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> <a class="btn secondary" href="https://onlinelibrary.wiley.com/user-registration" target="_blank">Register</a> </div> <div class="pull-right"> <a class="institutional-login-form-button" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=0&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolariscontentdisplay_WAR_scolariscontentdisplay_action=institution-access">Institutional login</a> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div></div>
<div class="institution-login-form-content" data-modal-title="Institutional login" style="display: none;">
<div class="form-content">
<div class="row-fluid access-content-wrapper">
<div class="span12">
<div class="section">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="obft__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="access-content-section"> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/>
</div>
<button class="btn primary" name="button" type="submit">Go</button>
</div>
<div class="message error" id="institutionLookupErrorDiv" style="display:none">
                        '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access.
                    </div>
</div>
<input id="entityId" name="entityId" type="hidden" value=""/>
</form>
<h4>Previously accessed institutions</h4>
<ul class="plain" id="previousInstitutions">
<li>(none)</li>
</ul>
</div>
<div class="section-content">
<div class="open-athens-login">
                Login using <a href="/openathens">OpenAthens</a>
</div>
</div>
</div>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_4_">
<span id="p_58_INSTANCE_4"></span>
<section class="portlet" id="portlet_58_INSTANCE_4">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="joiu__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_4" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <p>If you have a <strong>Wiley Online Library</strong> institutional username and password, enter them here.</p> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_4&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_4_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_4_fm" method="post" name="_58_INSTANCE_4_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_4_formDate" type="hidden" value="1740724988748"> <input class="field" id="_58_INSTANCE_4_saveLastPath" name="_58_INSTANCE_4_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_4_redirect" name="_58_INSTANCE_4_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD004370.pub4/full"> <input class="field" id="_58_INSTANCE_4_doActionAfterLogin" name="_58_INSTANCE_4_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_login"> Username </label> <input class="field clearable" id="_58_INSTANCE_4_login" name="_58_INSTANCE_4_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_password"> Password </label> <input class="field" id="_58_INSTANCE_4_password" name="_58_INSTANCE_4_password" type="password" value=""> </input></div> <input class="field" id="_58_INSTANCE_4_institutionalLogin" name="_58_INSTANCE_4_institutionalLogin" type="hidden" value="true"/> <span id="_58_INSTANCE_4_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div></div>
<div class="get-access-form-content" data-modal-title="Unlock gold-standard Cochrane evidence" style="display: none;">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="wpdq__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="readcube-checkout-container-outer"> <div class="row-fluid access-content-wrapper"> <div class="span6 access-left-content"> <div class="section"> <div class="section-content"> <p>Improve your health decisions with access to trusted, independent evidence from the Cochrane Library. Unlock this review for uninterrupted access.</p> <p>Still deciding? <a href="https://m.info.wiley.com/webApp/cochranenewsletter"> Sign up to our newsletter to learn more </a> </p> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title">Institutional users</h3> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/> </div> <button class="btn primary" name="button" type="submit">Go</button> </div> <div class="message error" id="institutionLookupErrorDiv" style="display:none"> '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access. </div> </div> <input id="entityId" name="entityId" type="hidden" value=""/> </form> <h4>Previously accessed institutions</h4> <ul class="plain" id="previousInstitutions"> <li>(none)</li> </ul> </div> <div class="section-content"> <div class="open-athens-login"> Login using <a href="/openathens">OpenAthens</a> </div> </div> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title"> Other access options </h3> <div class="section-content"> <ul class="plain"> <li> <a class="get-access-individual-login-button" href="/c/portal/login"> Individual access - via Wiley Online Library </a> </li> </ul> </div> </div> </div> </div> <div class="span6 access-right-content readcube-checkout-container"> <div class="section"> </div> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/> <input id="openlabel" name="openlabel" type="hidden" value="Open access"/> </div> </section> </div> </div> <!-- Scolaris Version: --> <script type="text/javascript">if(window._satellite){_satellite.pageBottom()};</script> </div> <script>(function(){function c(){var b=a.contentDocument||a.contentWindow.document;if(b){var d=b.createElement('script');d.innerHTML="window.__CF$cv$params={r:'918e7041ed1d1bdf',t:'MTc0MDcyNDk4OS4wMDAwMDA='};var a=document.createElement('script');a.nonce='';a.src='/cdn-cgi/challenge-platform/scripts/jsd/main.js';document.getElementsByTagName('head')[0].appendChild(a);";b.getElementsByTagName('head')[0].appendChild(d)}}if(document.body){var a=document.createElement('iframe');a.height=1;a.width=1;a.style.position='absolute';a.style.top=0;a.style.left=0;a.style.border='none';a.style.visibility='hidden';document.body.appendChild(a);if('loading'!==document.readyState)c();else if(window.addEventListener)document.addEventListener('DOMContentLoaded',c);else{var e=document.onreadystatechange||function(){};document.onreadystatechange=function(b){e(b);'loading'!==document.readyState&&(document.onreadystatechange=e,c())}}}})();</script></body> </html> 